Reproductive effects of the psychoactive beverage ayahuasca in male Wistar rats after chronic exposure

Santos, A. D. F. A., Vieira, A. L. S., Pic-Taylor, A., & Caldas, E. D. | Revista Brasileira de Farmacognosia | 9 March 2017

Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences

Heink, A., Katsikas, S., & Lange-Altman, T. | Journal of Psychoactive Drugs | 7 March 2017

Peyote as Commodity: An Examination of Market Actors and Access Mechanisms

Feeney, K. | Human Organization | 1 March 2017

Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder

Adams, T. G., Bloch, M. H., & Pittenger, C. | Journal of clinical psychopharmacology | 1 March 2017

Psychedelics and the science of self-experience

Nour, M. M., & Carhart-Harris, R. L. | The British Journal of Psychiatry | 1 March 2017

Synthesis of New Harmine Isoxazoles and Evaluation of their Potential Anti-Alzheimer, Anti-inflammatory, and Anticancer Activities

Filali, I., Romdhane, A., Znati, M., B Jannet, H., & Bouajila, J. | Medicinal Chemistry | 1 March 2017

Indole Alkaloids from Plants as Potential Leads for Antidepressant Drugs: A Mini Review

Hamid, H. A., Ramli, A. N., & Yusoff, M. M. | Frontiers in Pharmacology | 28 February 2017

LSD instead of 25I-NBOMe: The revival of LSD? A case report

Bodeau, S., Bennis, Y., Régnaut, O., Fabresse, N., Richeval, C., Humbert, L., ... & Lemaire-Hurtel, A. S. | Toxicologie Analytique et Clinique | 27 February 2017

Effects of Hallucinogens on Neuronal Activity

Lladó-Pelfort, L., Celada, P., Riga, M. S., Troyano-Rodríguez, E., Santana, N., & Artigas, F. | Current Topics in Behavioural Neuroscience | 26 February 2017

Ayahuasca dimethyltryptamine, and psychosis: a systematic review of human studies

dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | Therapeutic Advances in Psychopharmacology | 23 February 2017

Safety pharmacology of acute MDMA administration in healthy subjects

Vizeli, P., & Liechti, M. E. | Journal of Psychopharmacology | 21 February 2017

Hallucinogenic Drugs: A New Study Answers Old Questions about LSD

Halberstadt, A. L. | Current Biology | 20 February 2017

22-azidosalvinorin A exhibits antidepressant-like effect in mice

Fajemiroye, J. O., Prabhakar, P. R., da Cunha, C. L., Costa, E. A., & Zjawiony, J. K. | European Journal of Pharmacology | 17 February 2017

Altered Insula Connectivity Under MDMA

Walpola, I. C., Nest, T., Roseman, L., Erritzoe, D., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. | Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology | 14 February 2017

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects

Dolder, P. C., Schmid, Y., Steuer, A. E., Kraemer, T., Rentsch, K. M., Hammann, F., & Liechti, M. E. | Clinical Pharmacokinetics | 14 February 2017

The association of psychedelic use and opioid use disorders among illicit users in the United States

Pisano, V. D., Putnam, N. P., Kramer, H. M., Franciotti, K. J., Halpern, J. H., & Holden, S. C. | Journal of Psychopharmacology | 14 February 2017

Short term changes in the proteome of human cerebral organoids induced by 5-methoxy-N,N-dimethyltryptamine

Dakic, V., Nascimento, J. M., Sartore, R. C., de Moraes Maciel, R., de Araujo, D. B., Ribeiro, S., ... & Rehen, S. K. | bioRxiv | 13 February 2017

Science, spirituality, and ayahuasca: The problem of consciousness and spiritual ontologies in the academy

Apud, I. | Zygon | 12 February 2017

A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics

Cruz, A., Domingos, S., Gallardo, E., & Martinho, A. | Phytochemistry | 10 February 2017

Potential Antitumor Effect of Harmine in the Treatment of Thyroid Cancer

Ruan, S., Jia, F., & Li, J. | Evidence-Based Complementary and Alternative Medicine | 8 February 2017

Disrupted integration of sensory stimuli with information about the movement of the body as a mechanism explaining LSD-induced experience

Juszczak, G. R. | Medical Hypotheses | 3 February 2017

Effect of a Hallucinogenic Serotonin 5-HT2A Receptor Agonist on Visually-Guided, Hippocampal-Dependent Spatial Cognition in C57BL/6J Mice

Zhang, G., Cinalli, D., & Stackman, R. W. | Hippocampus | 1 February 2017

Prophylactic Ketamine Attenuates Learned Fear

McGowan, J. C., LaGamma, C. T., Lim, S. C., Tsitsiklis, M., Neria, Y., Brachman, R. A., & Denny, C. A. | Neuropsychopharmacology | 27 January 2017

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomised placebo-controlled trial

Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M., Pessoa, J., ... & Tofoli, L. | bioRxiv | 27 January 2017

The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation

Preller, K. H., Herdener, M., Pokorny, T., Planzer, A., Kraehenmann, R., Stämpfli, P., ... & Vollenweider, F. X. | Current Biology | 26 January 2017

Crystal Structure of an LSD-Bound Human Serotonin Receptor

Wacker, D., Wang, S., McCorvy, J. D., Betz, R. M., Venkatakrishnan, A. J., Levit, A., ... & Shoichet, B. K. | Cell | 26 January 2017

Reply to: Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion

da Frota Ribeiro, C. M., Sanacora, G., & Ostroff, R. | Biological Psychiatry | 23 January 2017

The fibrinolytic system: A new target for treatment of depression with psychedelics

Idell, R. D., Florova, G., Komissarov, A. A., Shetty, S., Girard, R. B. S., & Idell, S. | Medical Hypotheses | 23 January 2017

Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects

Vizeli, P., Schmid, Y., Prestin, K., zu Schwabedissen, H. E. M., & Liechti, M. E. | European Neuropsychopharmacology | 20 January 2017

Determination of Tryptamines and β-Carbolines in Ayahuasca Beverage Consumed During Brazilian Religious Ceremonies

Santos, M. C., Navickiene, S., & Gaujac, A. | Journal of AOAC International | 19 January 2017

Administration of ketamine for unipolar and bipolar depression

Kraus, C., Rabl, U., Vanicek, T., Carlberg, L., Popovic, A., Spies, M., ... & Willeit, M. | International Journal of Psychiatry in Clinical Practice | 18 January 2017

Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens

Halberstadt, A. L. | Current Topics in Behavioral Neurosciences | 18 January 2017

The Iboga Alkaloids

Lavaud, C., & Massiot, G. | Progress in the Chemistry of Organic Natural Products | 1 January 2017

Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?

Malcolm, B. J., & Lee, K. C. | Mental Health Clinician | 1 January 2017

Clinical potential of psilocybin as a treatment for mental health conditions

Daniel, J., & Haberman, M. | Mental Health Clinician | 1 January 2017

Treating drug dependence with the aid of ibogaine: A qualitative study

Schenberg, E. E., de Castro Comis, M. A., Alexandre, J. F. M., Chaves, B. D. R., Tófoli, L. F., & da Silveira, D. X. | Journal of Psychedelic Studies | 1 January 2017

Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects

Strajhar, P., Schmid, Y., Liakoni, E., Dolder, P. C., Rentsch, K. M., Kratschmar, D. V., ... & Liechti, M. E. | Journal of neuroendocrinology | 1 January 2017

Can 3,4,-methylenedioxymethamphetamine therapy be used to treat alcohol use disorder?

Sessa, B. | Journal of Psychedelic Studies | 30 December 2016

Phenomenology, Structure, and Dynamic of Psychedelic States

Preller, K. H., & Vollenweider, F. X. | Current Topics in Behavioral Neurosciences | 27 December 2016

The antiaddictive effects of ibogaine: A systematic literature review of human studies

dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | Journal of Psychedelic Studies | 20 December 2016

Conducting PTSD clinical trials on a Schedule I drug: MDMA

Knopf, A. | Alcoholism & Drug Abuse Weekly | 12 December 2016

A One-Dose Psychedelic Fix for Addiction?

Jacobson, R. | Scientific American Mind | 8 December 2016

Psilocybin: promising results in double-blind trials require confirmation by real-world evidence

Breckenridge, A., & Grobbee, D. E. | Journal of psychopharmacology | 6 December 2016

Psilocybin-assisted psychotherapy for dying cancer patients – aiding the final trip

Spiegel, D. | Journal of psychopharmacology | 6 December 2016

Psilocybin for depression and anxiety associated with life-threatening illnesses

McCorvy, J. D., Olsen, R. H., & Roth, B. L. | Journal of psychopharmacology | 6 December 2016

Harmine stimulates proliferation of human neural progenitors

Dakic, V., de Moraes Maciel, R., Drummond, H., Nascimento, J. M., Trindade, P., & Rehen, S. K. | PeerJ | 6 December 2016

Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration

Aarde, S. M., & Taffe, M. A. | Current Topics in Behavorial Neuroscience | 2 December 2016

The role of psychedelics in palliative care reconsidered: A case for psilocybin

Kelmendi, B., Corlett, P., Ranganathan, M., D'Souza, C., & Krystal, J. H. | Journal of psychopharmacology | 1 December 2016

Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology

Hartogsohn, I. | Journal of Psychopharmacology | 1 December 2016

Psilocybin and palliative end-of-life care

Shelton, R. C., & Hendricks, P. S. | Journal of Psychopharmacology | 1 December 2016

Psilocybin in end of life care: Implications for further research

Summergrad, P. | Journal of Psychopharmacology | 1 December 2016

Psilocybin: Psychotherapy or drug?

Goodwin, G. M. | Journal of Psychopharmacology | 1 December 2016

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., ... & Klinedinst, M. A. | Journal of Psychopharmacology | 1 December 2016

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., ... & Su, Z. | Journal of Psychopharmacology | 1 December 2016

Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future

Nutt, D. | Journal of Psychopharmacology | 1 December 2016

Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT

Ma, K. H., Liu, T. T., Weng, S. J., Chen, C. F. F., Huang, Y. S., Chueh, S. H., ... & Huang, W. S. | Scientific Reports | 1 December 2016

Ecstasy research: will increasing observational data aid our understanding of MDMA?

Amoroso, T. | The Lancet Psychiatry | 1 December 2016

The Therapeutic Potential of Ayahuasca

Coe, M. A., & McKenna, D. J. | Springer International Publishing | 1 December 2016

Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015

Heise, C. W., & Brooks, D. E. | Journal of medical toxicology | 28 November 2016

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology

De Gregorio, D., Comai, S., Posa, L., & Gobbi, G. | International Journal of Molecular Sciences | 23 November 2016

Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant

Zhu, W., Ding, Z., Zhang, Y., Shi, J., Hashimoto, K., & Lu, L. | Neuroscience Bulletin | 22 November 2016

Biosynthesis of the psychotropic plant diterpene salvinorin A: Discovery and characterization of the Salvia divinorum clerodienyl diphosphate synthase

Pelot, K. A., Mitchell, R., Kwon, M., Hagelthorn, D. M., Wardman, J. F., Chiang, A., ... & Zerbe, P. | The Plant Journal | 19 November 2016

Ketamine: The Glutamatergic Antidepressant and Its Efficacy

Tracy, D. K., Caddy, C., & Shergill, S. S. | Melatonin, Neuroprotective Agents and Antidepressant Therapy | 18 November 2016

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms

Barrett, F. S., Bradstreet, M. P., Leoutsakos, J. M. S., Johnson, M. W., & Griffiths, R. R. | Journal of Psychopharmacology | 17 November 2016

Decision-making in chronic ecstasy users: a systematic review

Betzler, F., Viohl, L., & Romanczuk‐Seiferth, N. | European Journal of Neuroscience | 15 November 2016

The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens

Canal, C. E., & Murnane, K. S. | Journal of Psychopharmacology | 15 November 2016

Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use

Morgan, C., McAndrew, A., Stevens, T., Nutt, D., & Lawn, W. | Current Opinion in Behavioral Sciences | 15 November 2016

Cognitive and behavioural effects induced by social stress plus MDMA administration in mice

García-Pardo, M. P., Roger-Sánchez, C., Rodríguez-Arias, M., Miñarro, J., & Aguilar, M. A. | Behavioural Brain Research | 10 November 2016

Potential Psychiatric Uses for MDMA

Klosinski, B. B., & Mithoefer, M. C. | Clinical Pharmacology & Therapeutics | 9 November 2016

Psychedelics as Medicines: An emerging new paradigm

Nichols, D. E., Johnson, M. W., & Nichols, C. D. | Clinical Pharmacology & Therapeutics | 4 November 2016

Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies

Han, Y., Chen, J., Zou, D., Zheng, P., Li, Q., Wang, H., ... & Xie, P. | Neuropsychiatric Disease and Treatment | 3 November 2016

Rehabilitating LSD history in postwar America: Dilworth Wayne Woolley and the serotonin hypothesis of mental illness

Hewitt, K. | History of Science | 2 November 2016

Australia should be initiating a psychedelic research program: What are the barriers?

Strauss, N., Bright, S. J., & Williams, M. L. | Australian and New Zealand Journal of Psychiatry | 1 November 2016

MOLECULAR DOCKING STUDIES ON THE THERAPEUTIC TARGETS OF ALZHEIMER DISEASE (ACHE AND BCHE) USING NATURAL BIOACTIVE ALKALOIDS

Jyothi, P., & Yellamma, K. | International Journal of Pharmacy and Pharmaceutical Sciences | 1 November 2016

Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., & Hallak, J. E. | Neuroscience & Biobehavioral Reviews | 31 October 2016

Classic Psychedelics and Rational Suicide in the Elderly: Exploring the Potential Utility of a Reemerging Treatment Paradigm

Hendricks, P. S., & Grob, C. S. | Rational Suicide in the Elderly | 29 October 2016

Role of psilocybin in the treatment of depression

Mahapatra, A., & Gupta, R. | Therapeutic Advances in Psychopharmacology | 27 October 2016

Of Roots and Fruits A Comparison of Psychedelic and Nonpsychedelic Mystical Experiences

Yaden, D. B., Le Nguyen, K. D., Kern, M. L., Belser, A. B., Eichstaedt, J. C., Iwry, J., ... & Newberg, A. B. | Journal of Humanistic Psychology | 24 October 2016

Creativity and Psychoactive Substance Use: A Systematic Review

Iszáj, F., Griffiths, M. D., & Demetrovics, Z. | International Journal of Mental Health and Addiction | 20 October 2016

Medicine, religion and ayahuasca in Catalonia. Considering ayahuasca networks from a medical anthropology perspective

Apud, I., & Romaní, O. | International Journal of Drug Policy | 18 October 2016

Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression

Papp, M., Gruca, P., Lason-Tyburkiewicz, M., & Willner, P. | Behavioural Pharmacology | 18 October 2016

Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism

Bogenschutz, M. P., & Forcehimes, A. A. | Journal of Humanistic Psychology | 16 October 2016

Alterations of consciousness and mystical-type experiences after acute LSD in humans

Liechti, M. E., Dolder, P. C., & Schmid, Y. | Psychopharmacology | 7 October 2016

Psychological effects of MDMA

Wieliczko, M. J. | Doctoral dissertation, Canterbury Christ Church University | 4 October 2016

A Double-Blinded, Randomized, Placebo-Controlled Sub-Dissociative Dose Ketamine Pilot Study in the Treatment of Acute Depression and Suicidality in a Military Emergency Department Setting

Burger, J., Capobianco, M., Lovern, R., Boche, B., Ross, E., Darracq, M. A., & McLay, R. | Military Medicine | 1 October 2016

Psychedelics in the treatment of unipolar mood disorders: A systematic review

Rucker, J. J., Jelen, L. A., Flynn, S., Frowde, K. D., & Young, A. H. | Journal of Psychopharmacology | 1 October 2016

Lysergic Acid Diethylamide and mystical experiences

Lyvers, M. | The neuropathology of drug addictions and substance misuse | 1 October 2016

The Relationship between depression and use of ecstasy among adolescents in Taiwan

Lee, K. H., Su, C. H., Hsiao, R. C., Yen, C. N., & Yen, C. F. | Neuropsychiatry | 1 October 2016

The Entheogen Reformation

Roberts, T. B. | Association for Transpersonal Psychology | 1 October 2016

Psychedelic Psychotherapy Insights From 25 Years of Research

Richards, W. A. | Journal of Humanistic Psychology | 29 September 2016

A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4 Methylendioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction

Darracq, M. A., Thornton, S. L., Minns, A. B., & Gerona, R. R. | Journal of Psychoactive Drugs | 16 September 2016

Ayahuasca and Sumak Kawsay: Challenges to the Implementation of the Principle of “Buen Vivir,” Religious Freedom, and Cultural Heritage Protection

Irigaray, C. T. J., Girard, P., Irigaray, M., & Silva, C. J. | Anthropology of Consciousness | 15 September 2016

Ayahuasca Treatment Center Safety for the Western Seeker

Ray, R. R., & Lassiter, K. S. | Anthropology of Consciousness | 15 September 2016

The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells

Szabo, A., Kovacs, A., Riba, J., Djurovic, S., Rajnavolgyi, E., & Frecska, E. | Frontiers in Neuroscience | 14 September 2016

Psychological and neuropsychological assessment of regular hoasca users

Barbosa, P. C. R., Strassman, R. J., da Silveira, D. X., Areco, K., Hoy, R., Pommy, J., ... & Bogenschutz, M. | Comprehensive Psychiatry | 12 September 2016

Clinical and biological predictors of ketamine response in treatment-resistant major depression: Review

Romeo, B., Choucha, W., Fossati, P., & Rotge, J. Y. | L'Encephale | 9 September 2016

Ketamine Treatment and Global Brain Connectivity in Major Depression

Abdallah, C. G., Averill, L. A., Collins, K. A., Geha, P., Schwartz, J., Averill, C., ... & Iosifescu, D. V. | Neuropsychopharmacology | 8 September 2016

Ketamine: Future Treatment For Unresponsive Depression?

Frere, M., & Tepper, J. | Irish Medical Journal | 1 September 2016

The Resurrection Of Psychedelic Psychiatry And Its Role In Addiction Treatment

Skocylas, R. | UBC Medical Journal | 1 September 2016

DPS en HPPD: signalering, diagnostiek en behandeling van persistente waarnemingsstoornissen na partydrugs

Alderliefste, G. J. | Verslaving | 30 August 2016

Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences

Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S., MacLean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. R. | Journal of Psychopharmacology | 30 August 2016

The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies

Vegting, Y., Reneman, L., & Booij, J. | Psychopharmacology | 28 August 2016

The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?

Bershad, A. K., Miller, M. A., Baggott, M. J., & de Wit, H. | Journal of Psychopharmacology | 25 August 2016

Ketamine for Depression: An Update

Murrough, J. W. | Biological Psychiatry | 24 August 2016

It’s time to take psilocybin seriously as a possible treatment for substance use disorders.

Bogenschutz, M. P. | The American Journal of Drug and Alcohol Abuse | 24 August 2016

Psilocybin: panacea or placebo?

Hendrie, C., & Pickles, A. | The Lancet Psychiatry | 24 August 2016

Question-based Drug Development for psilocybin – Authors’ reply

Carhart-Harris, R., Nutt, D. | The Lancet Psychiatry | 24 August 2016

Question-based Drug Development for psilocybin

Dijkstra, F. M., Jacobs, G. E., & Cohen, A. F. | The Lancet Psychiatry | 24 August 2016

Return of the psychedelics: Psilocybin for treatment resistant depression

Patra, S. | Asian Journal of Psychiatry | 23 August 2016

The antidepressant effect of ketamine: Mediated by AMPA receptors?

Inta, D., Sprengel, R., Borgwardt, S., Lang, U. E., & Gass, P. | European Neuropsychopharmacology | 20 August 2016

The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors

De Gregorio, D., Posa, L., Ochoa-Sanchez, R., McLaughlin, R., Maione, S., Comai, S., & Gobbi, G. | Pharmacological Research | 17 August 2016

Psilocybin for treating substance use disorders?

de Veen, B. T., Schellekens, A. F., Verheij, M. M., & Homberg, J. R. | Expert Review of Neurotherapeutics | 12 August 2016

The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving

Sweat, N. W., Bates, L. W., & Hendricks, P. S. | Journal of Psychoactive Drugs | 11 August 2016

The Psychedelic Policy Quagmire: Health, Law, Freedom, and Society

Van Hagen, A. G. | BJPsych Bull | 11 August 2016

Semantic activation in LSD: evidence from picture naming

Family, N., Vinson, D., Vigliocco, G., Kaelen, M., Bolstridge, M., Nutt, D. J., & Carhart-Harris, R. L. | Language, Cognition and Neuroscience | 11 August 2016

Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study

Xu, X. | Doctoral dissertation, University of Pittsburgh | 8 August 2016

New use for an old drug: oral ketamine for treatment-resistant depression

Swiatek, K. M., Jordan, K., & Coffman, J. | BMJ Case Reports | 3 August 2016

Acid Brothers: Henry Beecher, Timothy Leary, and the psychedelic of the century

Moreno, J. D. | Perspectives in Biology and Medicine | 1 August 2016

Investigation of Personality Change Following MDMA-Assisted Psychotherapy for Post Traumatic Stress Disorder

Wagner, M., Mithoefer, M., Mithoefer, A., MacAulay, R., Jerome, L., Bazaar-Klosinski, B., & Doblin, R. | Archives of Clinical Neuropsychology | 1 August 2016

Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics

Tófoli, L. F., & de Araujo, D. B. | International Review of Neurobiology | 25 July 2016

Neurovascular Plasticity of the Hippocampus One Week after a Single Dose of Ketamine in Genetic Rat Model of Depression

Ardalan, M., Wegener, G., Polsinelli, B., Madsen, T. M., & Nyengaard, J. R. | Hippocampus | 21 July 2016

Long-term follow up of psilocybin-assisted smoking cessation

Garcia-Romeu, A. P., , Griffiths, R. R., & Johnson, M. W. | The American Journal of Drug and Alcohol Abuse | 21 July 2016

Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking

Kuypers, K. P. C., Riba, J., de la Fuente Revenga, M., Barker, S., Theunissen, E. L., & Ramaekers, J. G. | Psychopharmacology | 19 July 2016

A Public-Health-Based Vision for the Management and Regulation of Psychedelics

Haden, M., Emerson, B., & Tupper, K. W. | Journal of Psychoactive Drugs | 18 July 2016

MDMA as a Probe and Treatment for Social Behaviors

Heifets, B. D., & Malenka, R. C. | Cell | 14 July 2016

From Psychiatry to Flower Power and Back Again: The Amazing Story of Lysergic Acid Diethylamide

Mucke, H. A. | ASSAY and Drug Development Technologies | 8 July 2016

MDMA and PTSD treatment: “PTSD: From novel pathophysiology to innovative therapeutics”

Sessa, B. | Neuroscience Letters | 6 July 2016

Efficacy and safety of ketamine in bipolar depression: A systematic review

Alberich, S., Martínez-Cengotitabengoa, M., López, P., Zorrilla, I., Núñez, N., Vieta, E., & González-Pinto, A. | Revista de psiquiatria y salud mental | 4 July 2016

Clinical Applications of Hallucinogens: A Review

Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. | Experimental and clinical psychopharmacology | 1 July 2016

A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience

Gallimore, A. R. and Strassman, R. | Frontiers in Pharmacology | 30 June 2016

Major Depressive Disorder Induced by Chronic Ketamine Abuse: A Case Report

Chang, H., Huang, M. C., & Chen, L. Y. | The Primary Care Companion for CNS Disorders | 23 June 2016

Spirituality, drugs, and tourism: tourists’ and shamans’ experiences of ayahuasca in Iquitos, Peru

Prayag, G., Mura, P., Hall, C. M., & Fontaine, J. | Tourism Recreation Research | 22 June 2016

Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors

Ponzoni, L., Daniela, B., & Sala, M. | Psychopharmacology | 16 June 2016

Letter to the Editor: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity

Hashimoto, K. | Psychological medicine | 10 June 2016

The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging

dos Santos, R. G., Balthazar, F. M., Bouso, J. C., & Hallak, J. E. | Journal of Psychopharmacology | 10 June 2016

Salvia divinorum: toxicological aspects and analysis in human biological specimens

Margalho, C., Corte-Real, F., López-Rivadulla, M., & Gallardo, E. | Bioanalysis | 9 June 2016

Magic mushroom compound is a potential treatment for patients with major depression

Carhart-Harris, R. L. | Nursing Standard | 8 June 2016

Underreporting of ecstasy use among high school seniors in the US

Palamar, J. J., Keyes, K., & Cleland, C. M. | Drug and Alcohol Dependence | 6 June 2016

Return of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2’S,4’S)-lysergic acid 2,4-dimethylazetidide (LSZ)

Brandt, S. D., Kavanagh, P. V., Westphal, F., Elliott, S. P., Wallach, J., Colestock, T., ... & Halberstadt, A. L. | Drug testing and analysis | 6 June 2016

Serotonin antagonists fail to alter MDMA self-administration in rats

Schenk, S., Foote, J., Aronsen, D., Bukholt, N., Highgate, Q., Van de Wetering, R., & Webster, J. | Pharmacology Biochemistry and Behavior | 2 June 2016

Potential involvement of serotonergic signaling in ketamine’s antidepressant actions: A critical review

du Jardin, K. G., Müller, H. K., Elfving, B., Dale, E., Wegener, G., & Sanchez, C. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2 June 2016

The potential use of ayahuasca in psychiatry

Frecska, E., Bokor, P., Andrassy, G., & Kovacs, A. | Neuropsychopharmacologia Hungarica | 1 June 2016

Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial

Jafarinia, M., Afarideh, M., Tafakhori, A., Arbabi, M., Ghajar, A., Noorbala, A. A., ... & Akhondzadeh, S. | Journal of Affective Disorders | 1 June 2016

Using the Theory of Planned Behavior to predict implementation of harm reduction strategies among MDMA/ecstasy users

Davis, A. K., & Rosenberg, H. | Psychology of Addictive Behaviors | 1 June 2016

LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality

Dolder, P., Schmidt, Y., Müller, F., Borgwardt, S. Liechti, M. | Neuropsychopharmacology | 1 June 2016

Ketamine abuse potential and use disorder

Liu, Y., Lin, D., Wu, B., & Zhou, W. | Brain research bulletin | 31 May 2016

Ibogaine and addiction in the animal model, a systematic review and meta-analysis

Belgers, M., Leenaars, M., Homberg, J. R., Ritskes-Hoitinga, M., Schellekens, A. F. A., & Hooijmans, C. R. | Translational psychiatry | 31 May 2016

In reply – on the toxicity of ibogaine

Brunt, T. M., & Litjens, R. P. | Clinical toxicology | 31 May 2016

On the toxicity of ibogaine

Yip, L., & Deng, J. F. | Clinical Toxicology | 31 May 2016

±3,4-Methylenedioxymethamphetamine: Treating PTSD in The Modern World

Baxter, A. | Academic Excellence Showcase Schedule | 26 May 2016

Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans

Nunes, A. A., dos Santos, R. G., Osório, F. L., Sanches, R. F., Crippa, J. A. S., & Hallak, J. E. | Journal of psychoactive drugs | 26 May 2016

Human Pharmacology of Mephedrone in Comparison to MDMA

Papaseit, E., Pérez-Mañá, C., Mateus, J. A., Pujadas, M., Fonseca, F., Torrens, M., ... & Farré, M. | Neuropsychopharmacology | 20 May 2016

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

Rickly, A., Moning, O., Hoener, M., Liechti, M. | European Neuropsychopharmacology | 20 May 2016

Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)

Nour, M. M., Evans, L., Nutt, D., & Carhart-Harris, R. L. | Frontiers in Human Neuroscience | 20 May 2016

Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior

Mallick, F., & McCullumsmith, C. B. | Current psychiatry reports | 19 May 2016

Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans

Shebloski, K. L., & Broadway, J. M. | Frontiers in Psychology | 19 May 2016

Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration

Oram, M. | History of psychiatry | 18 May 2016

Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report

Cloutier-Gill, L., Wood, E., Millar, T., Ferris, C., & Eugenia Socias, M. | Journal of Psychoactive Drugs | 18 May 2016

Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits

Zhang, M. W., & Ho, R. C. | Ethics & Behavior | 17 May 2016

Psilocybin with psychological support for treatment-resistant depression

Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., ... & Taylor, D. | The Lancet Psychiatry | 17 May 2016

Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., ... & Taylor, D. | The Lancet Psychiatry | 17 May 2016

“Quite a Profoundly Strange Experience”: An Analysis of the Experiences of Salvia divinorum Users

Hutton, F., Kivell, B., & Boyle, O. | Journal of Psychoactive Drugs | 13 May 2016

Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression

Zhong, X., He, H., Zhang, C., Wang, Z., Jiang, M., Li, Q., ... & Huang, X. | Journal of Affective Disorders | 12 May 2016

Glutamate and GABA Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine

Lener, M. S., Niciu, M. J., Ballard, E. D., Park, M., Park, L. T., Nugent, A., & Zarate, C. A. | Biological Psychiatry | 12 May 2016

Treatment of heroin dependence with ibogaine

Schellekens, A., Oosteren, T., Knuijver, T., & Belgers, M. | European Psychiatry | 12 May 2016

Ketamine: stimulating antidepressant treatment?

Malhi, G. S., Byrow, Y., Cassidy, F., Cipriani, A., Demyttenaere, K., Frye, M. A., ... & McShane, R. | British Journal of Psychiatry Open | 11 May 2016

Effects of low dose ibogaine on subjective mood state and psychological performance

Forsyth, B., Machado, L., Jowett, T., Jakobi, H., Garbe, K., Winter, H., & Glue, P. | Journal of Ethnopharmacology | 11 May 2016

On the Origin of the Genus Psilocybe and Its Potential Ritual Use in Ancient Africa and Europe

Froese, T., Guzmán, G., & Guzmán-Dávalos, L. | Economic Botany | 10 May 2016

LSD-induced entropic brain activity predicts subsequent personality change

Lebedev, A.V., Kaelen, M., Lövdén, M., Nilsson, J. Feilding, A., Nutt, D. J., Carhart-Harris, R. L. | Hum Brain Mapp | 6 May 2016

Depression: Ketamine steps out of the darkness

Malinow, R. | Nature | 4 May 2016

Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue—Behavioural, pharmacokinetic and metabolic studies in the Wistar rat

Horsley, R. R., Lhotkova, E., Hajkova, K., Jurasek, B., Kuchar, M., & Palenicek, T. | Brain Research Bulletin | 4 May 2016

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., ... & Dossou, K. S. | Nature | 4 May 2016

LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion

Roseman, L., Sereno, M. I., Leech, R., Kaelen, M., Orban, C., McGonigle, J., ... & Carhart‐Harris, R. L. | Human Brain Mapping | 29 April 2016

Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy

Amoroso, T., & Workman, M. | Journal of psychopharmacology | 26 April 2016

Neuropharmacology of N,N-Dimethyltryptamine

Carbonaro, T. M., & Gatch, M. B. | Brain Research Bulletin | 25 April 2016

Anxiety Mescaline

Kyzar, E. J., Collins, C., Gaikwad, S., Green, J., Roth, A., Monnig, L., ... & Stewart, A. M.

Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use

Walsh, Z., Hendricks, P. S., Smith, S., Kosson, D. S., Thiessen, M. S., Lucas, P., & Swogger, M. T. | Journal of psychopharmacology (Oxford, England) | 19 April 2016

Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial

Dakwar, E., Hart, C. L., Levin, F. R., Nunes, E. V., & Foltin, R. W. | Molecular Psychiatry | 19 April 2016

Effects of serotonin 2A/1A receptor stimulation on social exclusion processing

Preller, K. H., Pokorny, T., Hock, A., Kraehenmann, R., Stämpfli, P., Seifritz, E., ... & Vollenweider, F. X. | Proceedings of the National Academy of Sciences | 18 April 2016

Harmine stimulates neurogenesis of human neural cells in vitro

Dakic, V., de Moraes Maciel, R., Drummond, H., Nascimento, J. M., Trindade, P., & Rehen, S. K. | PeerJ Preprints | 14 April 2016

How psychoactive drugs shape human culture: a multi-disciplinary perspective

Wadley, G. | Brain Research Bulletin | 12 April 2016

LSD modulates music-induced imagery via changes in parahippocampal connectivity

Kaelen, M., Roseman, L., Kahan, J., Santos-Ribeiro, A., Orban, C., Lorenz, R., ... & Wall, M. B. | European Neuropsychopharmacology | 12 April 2016

Neural correlates of the LSD experience revealed by multimodal neuroimaging

Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., ... & Leech, R. | Proceedings of the National Academy of Sciences | 11 April 2016

Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution

Tagliazucchi, E., Roseman, L., Kaelen, M., Orban, C., Muthukumaraswamy, S. D., Murphy, K., ... & Bullmore, E. | Current Biology | 11 April 2016

Ketamine for Treatment-Resistant Unipolar and Bipolar Major Depression: Critical Review and Implications for Clinical Practice

Bobo, W. V., Voort, J. L. V., Croarkin, P. E., Leung, J. G., Tye, S. J., & Frye, M. A. | Depression and Anxiety | 6 April 2016

Ketamine for treatment-resistant depression: recent developments and clinical applications

Schwartz, J., Murrough, J. W., & Iosifescu, D. V. | Evidence-based mental health | 6 April 2016

Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA

Mithoefer, M. C., Grob, C. S., & Brewerton, T. D. | The Lancet Psychiatry | 5 April 2016

Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents

Mash, D. C., Ameer, B., Prou, D., Howes, J. F., & Maillet, E. L. | Journal of psychopharmacology (Oxford, England) | 4 April 2016

Race-Based Trauma: The Challenge and Promise of MDMA-Assisted Psychotherapy

Williams, M. T. | MAPS Bulletin | 1 April 2016

Can ecstasy treat the agony of PTSD?

Mithoefer, M. | European Psychiatry | 1 April 2016

A systematic review of the effects of novel psychoactive substances ‘legal highs’ on people with severe mental illness

Gray, R., Bressington, D., Hughes, E., & Ivanecka, A. | Journal of Psychiatric and Mental Health Nursing | 1 April 2016

Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?

Szabo, A., & Frecska, E. | Neural Regeneration Research | 1 April 2016

Depressant Effects of Salvia divinorum Involve Disruption of Physiological Sleep

González‐Trujano, M. E., Brindis, F., López‐Ruiz, E., Ramírez‐Salado, I., Martínez, A., & Pellicer, F. | Phytotherapy Research | 1 April 2016

The routes of a plant: ayahuasca and the global networks of Santo Daime

Lowell, J. T., & Adams, P. C. | Social & Cultural Geography | 31 March 2016

Controversies of the effect of ketamine on cognition

Zhang, M. W., & Ho, R. | Frontiers in Psychiatry | 29 March 2016

Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Rubi, L., Eckert, D., Boehm, S., Hilber, K., & Koenig, X. | Cardiovascular Toxicology | 28 March 2016

Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans

Valle, M., Maqueda, A. E., Rabella, M., Rodríguez-Pujadas, A., Antonijoan, R. M., Romero, S., ... & Feilding, A. | European Neuropsychopharmacology | 25 March 2016

Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., & Hallak, J. E. | Revista Brasileira de Psiquiatria | 24 March 2016

Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide

Speth, J., Speth, C., Kaelen, M., Schloerscheidt, A. M., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. | Journal of psychopharmacology | 1 April 2016

Lysergic acid diethylamide: a drug of ‘use’?

Das, S., Barnwal, P., Ramasamy, A., Sen, S., & Mondal, S. | Therapeutic Advances in Psychopharmacology | 23 March 2016

Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models

Kyzar, E. J., & Kalueff, A. V. | Zebrafish | 22 March 2016

Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J., Zuardi, A. W., & Hallak, J. E. | Therapeutic Advances in Psychopharmacology | 18 March 2016

Effects of 3,4-Methylenedioxymethamphetamine on Patient Utterances in a Psychotherapeutic Setting

Corey, V. R., Pisano, V. D., & Halpern, J. H. | The Journal of Nervous and Mental Disease | 17 March 2016

Meta-analysis of executive functioning in ecstasy/polydrug users

Roberts, C. A., Jones, A., & Montgomery, C. | Psychological medicine | 11 March 2016

Ayahuasca: pharmacology, neuroscience and therapeutic potential

Domínguez-Clavé, E., Soler, J., Elices, M., Pascual, J. C., Álvarez, E., de la Fuente Revenga, M., ... & Riba, J. | Brain Research Bulletin | 11 March 2016

Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective

Kuypers, K. P., Theunissen, E. L., van Wel, J. H., Perna, E. B. D. S. F., Linssen, A., Sambeth, A., ... & Ramaekers, J. G. | PloS one | 23 Februari 2016

Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting

Baggott, M. J., Coyle, J. R., Siegrist, J. D., Garrison, K. J., Galloway, G. P., & Mendelson, J. E. | Journal of psychopharmacology (Oxford, England) | 15 February 2016

Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans.

Johnson, M. W., MacLean, K. A., Caspers, M. J., Prisinzano, T. E., & Griffiths, R. R. | Journal of psychopharmacology (Oxford, England) | 15 February 2016

From mice to men: can ketamine enhance resilience to stress?

Price, R. B. | Biological Psychiatry | 15 February 2016

Naltrexone but not ketanserin antagonizes the subjective, cardiovascular and neuroendocrine effects of salvinorin-A in humans

Maqueda, A. E., Valle, M., Addy, P. H., Antonijoan, R. M., Puntes, M., Coimbra, J., ... & Barker, S. | International Journal of Neuropsychopharmacology | 12 Februari 2016

Ascending single-dose, double-blind, placebo-controlled safety study of noribogaine in opioid-dependent patients

Glue, P., Cape, G., Tunnicliff, D., Lockhart, M., Lam, F., Hung, N., ... & Howes, J. | Clinical Pharmacology in Drug Development | 10 February 2016

The therapeutic potentials of ayahuasca: possible effects against various diseases of civilization

Frecska, E., Bokor, P., & Winkelman, M. | Frontiers in Pharmacology | 8 February 2016

Acute effects of LSD on circulating steroid levels in healthy subjects.

Strajhar, P., Schmid, Y., Liakoni, E., Dolder, P. C., Rentsch, K. M., Kratschmar, D. V., ... & Liechti, M. E. | Journal of Neuroendocrinology | 6 February 2016

Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms

Jiang, X. L., Shen, H. W., & Yu, A. M. | Pharmacological Reports | 5 Februari 2016

Should ketamine be used for the clinical treatment of depression?

Arunogiri, S., Keks, N. A., & Hope, J. | Australasian Psychiatry | 5 February 2016

The paradoxical psychological effects of lysergic acid diethylamide (LSD).

Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., ... & Nutt, D. J. | Psychological medicine | 5 February 2016

Psychedelics

Nichols, D. E. | Pharmacological reviews | 3 February 2016

Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis)

Ballesta, S., Reymond, G., Pozzobon, M., & Duhamel, J. R. | PloS one | 3 February 2016

Oral ketamine for the treatment of pain and treatment-resistant depression

Schoevers, R. A., Chaves, T. V., Balukova, S. M., aan het Rot, M., & Kortekaas, R. | The British Journal of Psychiatry | 1 February 2016

The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study

Li, C. T., Chen, M. H., Lin, W. C., Hong, C. J., Yang, B. H., Liu, R. S., ... & Su, T. P. | Human Brain Mapping | 29 January 2016

How toxic is ibogaine?

Litjens, R. P., & Brunt, T. M. | Clinical Toxicology | 25 January 2016

Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience

Pokorny, T., Preller, K. H., Kraehenmann, R., & Vollenweider, F. X. | European Neuropsychopharmacology | 22 January 2016

Oxytocin receptor gene variation predicts subjective responses to MDMA

Bershad, A. K., Weafer, J. J., Kirkpatrick, M. G., Wardle, M. C., Miller, M. A., & de Wit, H. | Social neuroscience | 20 January 2016

Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-NN-dimethyltryptamine

Halberstadt, A. L. | Pharmacology Biochemistry and Behavior | 15 January 2016

Psychedelics and cognitive liberty: Reimagining drug policy through the prism of human rights.

Walsh, C. | International Journal of Drug Policy | 12 January

A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression

Singh, J. B., Fedgchin, M., Daly, E. J., De Boer, P., Cooper, K., Lim, P., ... & Kurian, B. | American Journal of Psychiatry | 11 January 2016

Psychedelic Medicine: Is it a False Dawn or a Renaissance?

Ali, A. Y. | International Journal of Emergency Mental Health and Human Resilience | 1 January 2016

Genotoxic evaluations in Wistar rats of the hallucinogenic plant extract ayahuasca

Pic-Taylor, A., Junior, W. M., Souza-Filho, J., Grisolia, C. K., & Caldas, E. D. | International Journal of Phytomedicine | 1 January 2016

As Molly Takes The Party Toll: MDMA Toxicity Presenting With Pulmonary Hemorrhage

Khalid, F., Kowsika, S., Ghobrial, I., & Rehman, S. | LUNG DISEASE DUE TO OTC AND ILLICITS: CASE REPORTS | 1 January 2016

Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent

Frau, L., Costa, G., Porceddu, P. F., Khairnar, A., Castelli, M. P., Ennas, M. G., ... & Morelli, M. | Journal of neurochemistry | 1 January 2016

Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats

Favaro, V. M., Yonamine, M., Soares, J. C. K., & Oliveira, M. G. M. | PloS one | 30 December 2015

Neuroimaging in moderate MDMA use: A systematic review

Mueller, F., Lenz, C., Steiner, M., Dolder, P. C., Walter, M., Lang, U. E., ... & Borgwardt, S. | Neuroscience & Biobehavioral Reviews | 30 December 2015

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study

Sanches, R. F., de Lima, O. F., Dos Santos, R. G., Macedo, L. R., Maia-de-Oliveira, J. P., Wichert-Ana, L., ... & Hallak, J. E. | Journal of clinical psychopharmacology | 8 December 2015

The epistemic innocence of psychedelic states

Letheby, C. | Consciousness and cognition | 7 December 2015

Salvia divinorum: An overview of the usage, misuse, and addiction processes

Mahendran, R., Lim, H. A., Tan, J., Chua, S. M., & Winslow, M. | Asia‐Pacific Psychiatry | 29 November 2015

Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities

Soler, J., Elices, M., Franquesca, A., Barker, S., Friedlander, P., Feilding, A., Pascual, J., Riba, J.| Psychopharmacology | 27 November 2015

Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey

Schindler, E. A., Gottschalk, C. H., Weil, M. J., Shapiro, R. E., Wright, D. A., & Sewell, R. A. | Journal of psychoactive drugs | 23 November 2015

Dimensions of the Psyche

Olivetti, K. | Jung Journal | 19 November 2015

The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder

Amoroso, T. | Journal of Psychoactive Drugs | 18 November 2015

Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class

Dinger, J., Woods, C., Brandt, S. D., Meyer, M. R., & Maurer, H. H. | Toxicology Letters | 17 November 2015

Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents

Carlini, E. A., & Maia, L. O. | 9 November 2015

New Studies on Hallucinogenic Mushrooms: History, Diversity, and Applications in Psychiatry

Guzmán, G. | International journal of medicinal mushrooms | 1 November 2015

Comparative phenomenology of psilocybin experiences in research and non-research settings

Carbonaro, T. M., Klinedinst, M., Johnson, M. W., & Griffiths, R. R. | Drug and Alcohol Dependence | 1 November 2015

Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts

Garcia-Romeu, A. P., Noorani, T., Griffiths, R. R., Johnson, M. W., Garey, L., Zvolensky, M. J., & Schmidt, N. B. | Drug and Alcohol Dependence | 1 November 2015

“Herbal seizures” – atypical symptoms after ibogaine intoxication: a case report

Breuer, L., Kasper, B. S., Schwarze, B., Gschossmann, J. M., Kornhuber, J., & Müller, H. H. | Journal of medical case reports | 31 October 2015

Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression

Romeo, B., Choucha, W., Fossati, P., & Rotge, J. Y. | Psychiatry research | 29 October 2015

Ayahuasca Tourism: Participants in Shamanic Rituals and their Personality Styles, Motivation, Benefits and Risks

Kavenská, V., & Simonová, H. | Journal of psychoactive drugs | 29 October 2015

Binge Ethanol and MDMA Combination Exacerbates Toxic Cardiac Effects by Inducing Cellular Stress

Navarro-Zaragoza, J., Ros-Simó, C., Milanés, M. V., Valverde, O., & Laorden, M. L. | PloS one | 28 October 2015

The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT1A and 5-HT2A receptors.

Riga, M. S., Bortolozzi, A., Campa, L., Artigas, F., & Celada, P. | Neuropharmacology | 20 October 2015

The Ups and Downs of 3,4-Methylenedioxymethamphetamine: Linking Subjective Effects to Spontaneous Brain Function

de Wit, H., Gorka, S. M., & Phan, K. L. | Biological psychiatry | 15 October 2015

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity

Carhart-Harris, R. L., Murphy, K., Leech, R., Erritzoe, D., Wall, M. B., Ferguson, B., ... & Tanner, M. | Biological psychiatry. | 15 October 2015

Sex differences and serotonergic mechanisms in the behavioural effects of psilocin

Tylš, F., Páleníček, T., Kadeřábek, L., Lipski, M., Kubešová, A., & Horáček, J. | Behavioural pharmacology | 12 October 2015

Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)

Brandt, S. D., Kavanagh, P. V., Westphal, F., Stratford, A., Elliott, S. P., Hoang, K., ... & Halberstadt, A. L. | Drug Testing and Analysis | 12 October 2015

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Barrett, F. S., Johnson, M. W., & Griffiths, R. R. | Journal of psychopharmacology | 6 October 2015

Banisteriopsis caapi, a Forgotten Potential Therapy for Parkinson’s Disease?

Djamshidian, A., Bernschneider‐Reif, S., Poewe, W., & Lees, A. J. | Movement Disorders Clinical Practice | 6 October 2015

Kappa Opioids, Salvinorin A and Major Depressive Disorder

T Taylor and Francesca Manzella | Current Neuropharmacology | 1 October 2015

Current Status of Ketamine and Related Therapies for Mood and Anxiety Disorders

Costi, S., Van Dam, N. T., & Murrough, J. W. | Current Behavioral Neuroscience Reports | 01 October 2015

Acute Biphasic Effects of Ayahuasca

Schenberg E.E., Alexandre J.F.M., Filev R., Cravo A.M., Sato J.R., Muthukumaraswamy S.D., et al. | PLoS ONE | 30 September 2015

Ketamine for depression: evidence, challenges and promise

Zarate, C. A., & Niciu, M. J. | World Psychiatry | 25 September 2015

The Prosocial Effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled Studies in Humans and Laboratory Animals

Kamilar-Britt, P., & Bedi, G. | Neuroscience & Biobehavioral Reviews | 25 September 2015

[Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca]

Szabo, A., Kazai, A., Frecska, E., & Brys, Z. | official journal of the Hungarian Association of Psychopharmacology | 17 September 2015

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning

Young, M. B., Andero, R., Ressler, K. J., & Howell, L. L. | Translational Psychiatry | 15 September 2015

Psychedelic medicine: a re-emerging therapeutic paradigm

Yensen, R., & Johnson, M. W. | Canadian Medical Association Journal | 08 Sep 2015

Psychedelic medicine: A re-emerging therapeutic paradigm

Tupper, K. W., Wood, E., Yensen, R., & Johnson, M. W. | CMAJ: Canadian Medical Association journal= journal de l'Association medicale canadienne | 08 September 2015

Salvinorin A, a kappa-opioid receptor (KOP-r) agonist hallucinogen: Pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders

Butelman, E., & Kreek, M. J. | Frontiers in Pharmacology | 08 Sep 2015

Harmine blocks herpes simplex virus infection through downregulating cellular NF-κB and MAPK pathways induced by oxidative stress

Chen, D., Su, A., Fu, Y., Wang, X., Lv, X., Xu, W., ... & Wu, Z. | Antiviral research | 5 September 2015

Ketamine for depression: the highs and lows

Kirby, T. | The Lancet Psychiatry | 1 September 2015

The paroxetine controversy: lessons for ketamine trials

Zhang, M. W., & Ho, R. C. | The lancet. Psychiatry | 1 September 2015

Psilocybin, psychological distress, and suicidality

Hendricks, P. S., Johnson, M. W., & Griffiths, R. R. | Journal of Psychopharmacology | 1 September 2015

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

Yang, C., Shirayama, Y., Zhang, J. C., Ren, Q., Yao, W., Ma, M., ... & Hashimoto, K. | Translational psychiatry | 1 September 2015

Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or ‘ecstasy’ and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices

Kamboj, S. K., Kilford, E. J., Minchin, S., Moss, A., Lawn, W., Das, R. K., ... & Freeman, T. P. | Journal of Psychopharmacology | 1 September 2015

Multisystem Organ Failure and Death Resulting From Ingestion of “Molly” (3,4-Methylenedioxymethamphetamine)

Shelton, C. P., & Rosini, J. M. | Journal of Emergency Nursing | 1 September 2015

Effects of LSD on grooming behavior in serotonin transporter heterozygous (Sert+/−) mice

Kyzar, E. J., Stewart, A. M., & Kalueff, A. V. | Behavioural brain research | 1 Sep 2015

MDMA, cannabis, and cocaine produce acute dissociative symptoms

van Heugten-Van der Kloet, D., Giesbrecht, T., van Wel, J., Bosker, W. M., Kuypers, K. P., Theunissen, E. L., ... & Ramaekers, J. G. | Psychiatry research | 30 August 2015

The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity

Kraehenmann, R., Schmidt, A., Friston, K., Preller, K. H., Seifritz, E., & Vollenweider, F. X. | NeuroImage: Clinical | 22 Aug 2015

Noribogaine is a G-Protein Biased κ-Opioid Receptor Agonist

Maillet, E. L., Milon, N., Heghinian, M. D., Fishback, J., Schürer, S. C., Garamszegi, N., & Mash, D. C. | Neuropharmacology | 21 Aug 2015

5-HT2A and mGlu2/3 receptor interactions: on their relevance to cognitive function and psychosis

Wischhof, L., & Koch, M. | Behavioural pharmacology | 19 Aug 2015

Mathematics and mysticism

Abraham, R. | Progress in biophysics and molecular biology | 14 Aug 2015

LSD enhances the emotional response to music

Kaelen, M., Barrett, F. S., Roseman, L., Lorenz, R., Family, N., Bolstridge, M., ... & Carhart-Harris, R. L. | Psychopharmacology | 11 August 2015

Lysergic Acid Diethylamide and Psilocybin Revisited

Geyer, M. A. | Biological psychiatry | 6 August 2015

LSD: a new treatment emerging from the past

Dyck, E. | CMAJ: Canadian Medical Association journal= journal de l'Association medicale canadienne | 04 Augustus 2015

Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations

Kometer, M., Pokorny, T., Seifritz, E., & Vollenweider, F. X. | Psychopharmacology | 01 Aug 2015

LSD-associated “Alice in Wonderland Syndrome”(AIWS): A Hallucinogen Persisting Perception Disorder (HPPD) Case Report.

Lev-Ran, S. | The Israel journal of psychiatry and related sciences | 1 August 2015

Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other Approaches

Al Jurdi, R. K., Swann, A., & Mathew, S. J. | Current psychiatry reports | 1 August 2015

5-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot Study

Wright, N. E., Strong, J. A., Gilbart, E. R., Shollenbarger, S. G., & Lisdahl, K. M. | PloS one | 31 July 2015

Greater sexual risk-taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study

May, A. L., & Parrott, A. C. | Human Psychopharmacology: Clinical and Experimental | 30 July 2015

The potential utility of some legal highs in CNS disorders

Davidson, C., & Schifano, F. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 29 July 2015

Developmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK

Singer, L. T., Moore, D. G., Min, M. O., Goodwin, J., Turner, J. J., Fulton, S., & Parrott, A. C. | Human Psychopharmacology: Clinical and Experimental | 28 July 2015

Antidepressant mechanism of ketamine: perspective from preclinical studies

Scheuing, L., Chiu, C. T., Liao, H. M., & Chuang, D. M. | Frontiers in Neuroscience | 21 July 2015

Acute ketamine challenge increases resting state prefrontal-hippocampal connectivity in both humans and rats.

Grimm, O., Gass, N., Weber-Fahr, W., Sartorius, A., Schenker, E., Spedding, M., ... & Meyer-Lindenberg, A. | Psychopharmacology | 18 July 2015

Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.

Spain, A., Howarth, C., Khrapitchev, A., Sharp, T., Sibson, N. R., & Martin, C. | Neuropharmacology | 17 July 2015

Ketamine induces anxiolytic effects in adult zebrafish: A multivariate statistics approach.

De Campos, E. G., Bruni, A. T., & De Martinis, B. S. | Behavioural Brain Research | 14 July 2015

‘Whatever you want to believe’ kaleidoscopic individualism and ayahuasca healing in Australia

Gearin, A. K. | The Australian Journal of Anthropology | 14 July 2015

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities

Szabo, A. | Frontiers in Immunology | 14 July 2015

A Model of Enlightened/Mystical/Awakened Experience.

de Castro, J. M. | Psychology of Religion and Spirituality | 13 July 2015

Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder

Papakostas, G. I., & Ionescu, D. F. | Molecular psychiatry | 7 July 2015

Perceptual distortions and delusional thinking following ketamine administration are related to increased pharmacological MRI signal changes in the parietal lobe

Stone, J., Kotoula, V., Dietrich, C., De Simoni, S., Krystal, J. H., & Mehta, M. A. | Journal of Psychopharmacology | 6 July 2015

Ayahuasca Alters Structural Parameters of the Rat Aorta

Pitol, D. L., Siéssere, S., Dos Santos, R. G., Nunes, M. R. M., Cecilio, H. J., Scalize, P. H., ... & Hallak, R. S. | Journal of cardiovascular pharmacology | 1 July 2015

Psychedelics and creativity: a review of the quantitative literature

Baggott, M. J. | PeerJ PrePrints | 30 June 2015

Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression

Newport, D. J., Carpenter, L. L., McDonald, W. M., Potash, J. B., Tohen, M., & Nemeroff, C. B. | American Journal of Psychiatry | 29 June 2015

Howard Becker in Hyperspace: Social Learning in an On-Line Drug Community

Rosino, M., & Linders, A. | Deviant Behavior | 26 June 2015

Paclitaxel combined with harmine inhibits the migration and invasion of gastric cancer cells through downregulation of cyclooxygenase‑2 expression

Sun, K., Tang, X. H., & Xie, Y. K. | Oncology Letters | 25 June 2015

Pharmacokinetics and concentration-effect relationship of oral LSD in humans

Dolder, P. C., Schmid, Y., Haschke, M., Rentsch, K. M., & Liechti, M. E. | International Journal of Neuropsychopharmacology | 24 June 2015

Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant

Ballard, E. D., Luckenbaugh, D. A., Richards, E. M., Walls, T. L., Brutsché, N. E., Ameli, R., ... & Zarate, C. A. | Journal of psychiatric research | 16 June 2015

Ketamine and Phencyclidine: the good, the bad and the unexpected

Lodge, D., & Mercier, M. S. | British journal of pharmacology | 15 June 2015

Restructuring consciousness -the psychedelic state in light of integrated information theory

Gallimore, A. R. | Frontiers in Human Neuroscience | 12 June 2015

A Thread in The Vine: The Deep Ecology of Contemporary Ayahuasca Discourse

Baker, J., & Coco, D. A. | - | 11 June 2015

Chronic MDMA induces neurochemical changes in the hippocampus of adolescent and young adult rats: Down-regulation of apoptotic markers

García-Cabrerizo, R., & García-Fuster, M. J. | Neurotoxicology | 9 June 2015

Antidepressant drug action – From rapid changes on network function to network rewiring

Rantamäki, T., & Yalcin, I. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 9 June 2015

In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept

Rodriguez, C. I., Kegeles, L. S., Levinson, A., Ogden, R. T., Mao, X., Milak, M. S., ... & Simpson, H. B. | Psychiatry Research: Neuroimaging | 6 June 2015

Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans

Maqueda, A. E., Valle, M., Addy, P. H., Antonijoan, R. M., Puntes, M., Coimbra, J., ... & Riba, J. | International Journal of Neuropsychopharmacology | 5 June 2015

The use of ketamine for the treatment of depression in the context of psychotic symptoms

da Frota Ribeiro, C. M., Sanacora, G., Hoffman, R., & Ostroff, R. | Biological Psychiatry | 4 June 2015

Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat.

Pic-Taylor, A., da Motta, L. G., de Morais, J. A., Junior, W. M., Santos, A. D. F. A., Campos, L. A., ... & Caldas, E. D. | Behavioural processes | 3 June 2015

Anti-mycobacterial and anti-inflammatory activity of Peganum harmala.

Davoodi, H., Ghaemi, E., Mazandarani, M., Shakeri, F., Javid, S. N., & Klishadi, M. | Journal of Chemical & Pharmaceutical Research | 2015

Harm Reduction or Psychedelic Support?

Ruane, D. | Dancecult: Journal of Electronic Dance Music Culture | 1 June 2015

MDMA for the treatment of mood disorder: all talk no substance?

Patel, R., & Titheradge, D. | Therapeutic Advances in Psychopharmacology | 1 June 2015

Single-Dose ketamine followed by daily D-Cycloserine in treatment-resistant bipolar depression.

Kantrowitz, J. T., Halberstam, B., & Gangwisch, J. | The Journal of clinical psychiatry | 1 June 2015

Serotonergic Hallucinogens and Emerging Targets for Addiction Pharmacotherapies

Ross, S. | Psychiatric Clinics of North America | 1 June 2012

Hunting and hallucinogens: The use psychoactive and other plants to improve the hunting ability of dogs.

Bennett, B. C., & Alarcón, R. | Journal of Ethnopharmacology | 28 May 2015

The positive effect on ketamine as a priming adjuvant in antidepressant treatment.

Melo, A., Kokras, N., Dalla, C., Ferreira, C., Ventura-Silva, A. P., Sousa, N., & Pêgo, J. M. | Translational Psychiatry | 26 May 2015

Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential

Rucker, J. J. | BMJ | 26 May 2015

Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin

Lebedev, A. V., Lövdén, M., Rosenthal, G., Feilding, A., Nutt, D. J., & Carhart‐Harris, R. L. | Human brain mapping | 22 May 2015

Noribogaine reduces nicotine self-administration in rats

Chang, Q., Hanania, T., Mash, D. C., & Maillet, E. L. | Journal of Psychopharmacology | 20 May 2015

Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile

Joules, R., Doyle, O. M., Schwarz, A. J., O’Daly, O. G., Brammer, M., Williams, S. C., & Mehta, M. A. | Psychopharmacology | 19 May 2015

Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or ‘ecstasy’ and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices.

Kamboj, S. K., Kilford, E. J., Minchin, S., Moss, A., Lawn, W., Das, R. K., ... & Freeman, T. P. | Journal of Psychopharmacology | 18 May 2015

Immunomodulatory activity of ketamine in human astroglial A172 cells: Possible relevance to its rapid antidepressant activity.

Yuhas, Y., Ashkenazi, S., Berent, E., & Weizman, A. | Journal of neuroimmunology | 15 May 2015

Intranasal drug delivery in neuropsychiatry: focus on intranasal ketamine for refractory depression.

Andrade, C. | The Journal of clinical psychiatry | May 2015

Therapeutic potential of psychedelic agents

Nour, M. M., & Krzanowski, J. | The British Journal of Psychiatry | 1 May 2015

MDMA for the treatment of mood disorder: all talk no substance?

Patel, R., & Titheradge, D. | Therapeutic Advances in Psychopharmacology | 1 May 2015

Ibogan, Tacaman, and Cytotoxic Bisindole Alkaloids from Tabernaemontana. Cononusine, an Iboga Alkaloid with Unusual Incorporation of a Pyrrolidone Moiety

Lim, K. H., Raja, V. J., Bradshaw, T. D., Lim, S. H., Low, Y. Y., & Kam, T. S. | Journal of natural products | 28 April 2015

Intimate insight: MDMA changes how people talk about significant others

Baggott, M. J., Kirkpatrick, M. G., Bedi, G., & de Wit, H. | Journal of Psychopharmacology | 28 April 2015

Fatty acid constituents of Peganum harmala plant using Gas Chromatography–Mass Spectroscopy

Moussa, T. A., & Almaghrabi, O. A. | Saudi Journal of Biological Sciences | 25 April 2015

Ketamine-A Narrative Review of Its Uses in Medicine

Radvansky, B. M., Puri, S., Sifonios, A. N., Eloy, J. D., & Le, V. | American Journal of Therapeutics | Apr 24 2015

The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey

Di Lorenzo, C., Coppola, G., Di Lorenzo, G., Bracaglia, M., Rossi, P., & Pierelli, F. | Cephalalgia | 22 April 2015

Ketamine-induced modulation of the thalamo-cortical network in healthy volunteers as a model for schizophrenia

Höflich, A., Hahn, A., Küblböck, M., Kranz, G. S., Vanicek, T., Windischberger, C., ... & Guertel, W. | The international journal of neuropsychopharmacology | 20 April 2015

A Note on the Docking of some Hallucinogens to the 5-HT2A Receptor

Gómez-Jeria, J. S., & Robles-Navarro, A. | Journal of Computational Methods in Molecular Design | April 2015

The hallucinogenic world of tryptamines: an updated review

Araújo, A. M., Carvalho, F., de Lourdes Bastos, M., de Pinho, P. G., & Carvalho, M. | Archives of toxicology | 16 April 2015

Mania following use of ibogaine: A case series

Marta, C. J., Ryan, W. C., Kopelowicz, A., & Koek, R. J. | The American Journal on Addictions | 14 April 2015

Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review

Iadarola, N. D., Niciu, M. J., Richards, E. M., Voort, J. L. V., Ballard, E. D., Lundin, N. B., ... & Zarate, C. A. | Therapeutic Advances in Chronic Disease | 13 April 2015

Concise synthesis of N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine starting with bufotenine from Brazilian Anadenanthera ssp..

Moreira, L. A., Murta, M. M., Gatto, C. C., Fagg, C. W., & dos Santos, M. L. | Natural product communications | 10 April 2015

The use of ketamine as an antidepressant: a systematic review and meta-analysis

Coyle, C. M., & Laws, K. R. | Human Psychopharmacology: Clinical and Experimental | 7 April 2015

Protecting the human rights of people who use psychedelics

Krebs, T. S. | The Lancet | 1 April 2015

Discovery of a new caerulescent Psilocybe mushroom in Germany: Psilocybe germanica sp.nov

Gartz, J., & Wiedemann, G. | Drug testing and analysis | 31 March 2015

Serotonergic psychedelics temporarily modify information transfer in humans

Alonso, J. F., Romero, S., Mañanas, M. À., & Riba, J. | International Journal of Neuropsychopharmacology | 28 March 2015

Current knowledge on the neurobiology of classical hallucinogens and their relevance for the treatment of mood and anxiety disorders

Kraehenmann, R. | European Psychiatry | 28 Mar 2015

5HT2a Receptors – a New Target for Depression?

Nutt, D. | European Psychiatry | 28 March 2015

The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making

Preller, K. H., Pokorny, T., Krähenmann, R., Dziobek, I., Stämpfli, P., & Vollenweider, F. X. | European Psychiatry | 28 March 2015

Research on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in mice

Zhuk, O., Jasicka-Misiak, I., Poliwoda, A., Kazakova, A., Godovan, V. V., Halama, M., & Wieczorek, P. P. | Toxins | 27 March 2015

MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults

Danforth, A. L., Struble, C. M., Yazar-Klosinski, B., & Grob, C. S. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 25 March 2015

Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary

Sessa, B., & Fischer, F. M. | Underground MDMA-, LSD-and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary | 24 March 2015

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

Osório, F. D. L., Sanches, R. F., Macedo, L. R., Dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., ... & Hallak, J. E. | Revista Brasileira de Psiquiatria | 20 March 2015

A brief survey of drug use and other activities preceding mystical-religious experiences

Baggott MJ. | @GitHub | 20 Mar 2015

Classic hallucinogens in the treatment of addictions

Bogenschutz, M. P., & Johnson, M. W. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 14 March 2015

A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication

Wang, P., Alvarez-Perez, J. C., Felsenfeld, D. P., Liu, H., Sivendran, S., Bender, A., ... & Stewart, A. F. | Nature medicine | 9 March 2015

Psychedelics not linked to mental health problems or suicidal behavior: A population study

Johansen, P. Ø., & Krebs, T. S. | Journal of Psychopharmacology | 5 March 2015

Prosocial effects of MDMA: A measure of generosity

Kirkpatrick, M., Delton, A. W., de Wit, H., & Robertson, T. E. | Journal of Psychopharmacology | 3 March 2015

Ketamine Users Have High Rates of Psychosis and/or Depression

Liang, H. J., Tang, K. L., Chan, F., Ungvari, G. S., & Tang, W. K. | Journal of addictions nursing | March 2015

Ketamine as a promising prototype for a new generation of rapid-acting antidepressants

Abdallah, C. G., Averill, L. A. and Krystal, J. H. | Annals of the New York Academy of Sciences | 27 Feb 2015

Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report

Szmulewicz, A. G., Valerio, M. P., & Smith, J. M. | International journal of bipolar disorders | 24 Februari 2015

Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction

Garcia-Romeu, A., Griffiths, R. R., & Johnson, M. W. | Current Drug Abuse Reviews | 23 February 2015

A Review of Lysergic Acid Diethylamide (LSD) in the Treatment of Addictions: Historical Perspectives and Future Prospects

Liester, M. B. | Current Drug Abuse Reviews | 23 February 2015

What Can Neuroscience Tell Us About the Potential of Psychedelics in Healthcare?

Mackenzie, R. | Current Drug Abuse Reviews | 23 February 2015

Editorial (Thematic Issue: Introduction to ‘Beneficial Effects of Psychedelics with a Special Focus on Addictions’)

Breeksema, J. J., & Kortekaas, R. | Current Drug Abuse Reviews | 23 February 2015

The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network

Palhano-Fontes, F., Andrade, K. C., Tofoli, L. F., Santos, A. C., Crippa, J., Hallak, J. A., ... Araujo, D. B. | PLoS One | 18 February 2015

The subjective experience of acute, experimentally-induced Salvia divinorum inebriation

Addy, P. H., Garcia-Romeu, A., Metzger, M., & Wade, J. | Journal of Psychopharmacology | 17 February 2015

Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder

Murrough, J. W., Collins, K. A., Fields, J., DeWilde, K. E., Phillips, M. L., Mathew, S. J., ... & Iosifescu, D. V. | Translational psychiatry | 17 February 2015

Neural correlates of change in major depressive disorder anhedonia following open-label ketamine

Lally, N., Nugent, A. C., Luckenbaugh, D. A., Niciu, M. J., Roiser, J. P., & Zarate, C. A. | Journal of Psychopharmacology | 17 February 2015

Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?

Majić, T., Schmidt, T. T., & Gallinat, J. | Journal of Psychopharmacology | 9 February 2015

Ex vivo effects of ibogaine on the activity of antioxidative enzymes in human erythrocytes

Nikolić-Kokić, A., Oreščanin-Dušić, Z., Spasojević, I., Slavić, M., Mijušković, A., Paškulin, R., ... & Blagojević, D. P. | Journal of ethnopharmacology | 7 Februari 2015

Ex vivo effects of ibogaine on the activity of antioxidative enzymes in human erythrocytes

Nikolić-Kokić, A., Oreščanin-Dušić, Z., Spasojević, I., Slavić, M., Mijušković, A., Paškulin, R., ... & Blagojević, D. P. | Journal of ethnopharmacology | 7 February 2015

The Effect of Repeated Ketamine Infusion Over Facial Emotion Recognition in Treatment-Resistant Depression: A Preliminary Report

Shiroma, P. R., Albott, C. S., Johns, B., Thuras, P., Wels, J., & Lim, K. O. | The Journal of Neuropsychiatry and Clinical Neurosciences | 6 February 2015

New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca

McKenna, D., & Riba, J. | Current Topics in Behavioral Neuroscience | 6 February 2015

Drug models of schizophrenia

Steeds, H., Carhart-Harris, R. L., & Stone, J. M. | Therapeutic Advances in Psychopharmacology | 5 February 2015

Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers

Glue, P., Winter, H., Garbe, K., Jakobi, H., Lyudin, A., Lenagh‐Glue, Z., & Hung, C. T. | The Journal of Clinical Pharmacology | 4 February 2015

Forbidden therapies: Santo Daime, ayahuasca, and the prohibition of entheogens in Western society

Blainey, M. G. | Journal of religion and health | 1 February 2015

Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia

Xu, K., Krystal, J. H., Ning, Y., He, H., Wang, D., Ke, X., ... & Fan, N. | Journal of psychiatric research | February 2015

Antidepressant actions of ketamine: from molecular mechanisms to clinical practice

Monteggia, L. M., & Zarate, C. | Current opinion in neurobiology | 1 February 2015

The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation

Koenig, X., & Hilber, K. | Molecules | 29 January 2015

Editorial (Thematic Issue: Introduction to ‘Beneficial Effects of Psychedelics with a Special Focus on Addictions’)

Kortekaas, R., & Breeksema, J. J. | Current Drug Abuse Reviews | 28 January 2015

Ayahuasca, Psychedelic Studies and Health Sciences: The Politics of Knowledge and Inquiry into an Amazonian Plant Brew

Tupper, K. W., & Labate, B. C. | Current Drug Abuse Reviews | 28 January 2015

Crisis Intervention Related to the Use of Psychoactive Substances in Recreational Settings – Evaluating the Kosmicare Project at Boom Festival

Carvalho, M. C., de Sousa, M. P., Frango, P., Dias, P., Carvalho, J., Rodrigues, M., & Rodrigues, T. | Current Drug Abuse Reviews | 28 January 2015

Psychedelics as Medicines for Substance Abuse Rehabilitation: Evaluating Treatments with LSD, Peyote, Ibogaine and Ayahuasca

Winkelman, M. | Current Drug Abuse Reviews | 28 January 2015

A Qualitative Report on the Subjective Experience of Intravenous Psilocybin Administered in an fMRI Environment

Turton, S., Nutt, D. J., & Carhart-Harris, R. L. | Current Drug Abuse Reviews | 28 January 2015

Salvinorin A and Related Compounds as Therapeutic Drugs for Psychostimulant-Related Disorders

dos Santos, R. G., Crippa, J. A., Machado-de-Sousa, J. P., & Hallak, J. E. | Current Drug Abuse Reviews | 28 January 2015

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans

Bouso, J. C., Palhano-Fontes, F., Rodríguez-Fornells, A., Ribeiro, S., Sanches, R., Crippa, J. A. S., ... & Riba, J. | European Neuropsychopharmacology | 16 January 2015

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. | Journal of Psychopharmacology | 13 January 2015

Recreational Use, Analysis and Toxicity of Tryptamines.

Tittarelli, R., Mannocchi, G., Pantano, F., & Saverio Romolo, F. | Current Neuropharmacology | 13 January 2015

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

Bogenschutz, M. P., Forcehimes, A. A, Pommy, J. A., Wilcox, C. E., Barbosa, P. C. R., & Strassman, R. J. | Journal of Psychopharmacology | 13 January 2015

Making a medicine out of MDMA

Sessa, B., & Nutt, D. | The British Journal of Psychiatry | 5 January 2015

Can psychedelic compounds play a part in drug dependence therapy?

Sessa, B., & Johnson, M. W. | The British Journal of Psychiatry | 5 January 2015

Psychedelic-facilitated smoking cessation: An online survey

Garcia-Romeu, A. P., Griffiths, R. R., & Johnson, M. W. | Drug and Alcohol Dependence | 1 January 2015

Serotonin 5-HT₂ receptor activation prevents allergic asthma in a mouse model.

Nau, F., Miller, J., Saravia, J., Ahlert, T., Yu, B., Happel, K. I., ... & Nichols, C. D. | American Journal of Physiology-Lung Cellular and Molecular Physiology | 1 January 2015

Ketamine interactions with biomarkers of stress: A randomized placebo-controlled repeated measures resting-state fMRI and PCASL pilot study in healthy men

Mahani, N. K., Niesters, M., van Osch, M. J., Oitzl, M., Veer, I., de Rooij, M., ... & Dahan, A. | NeuroImage | 29 December 2014

Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases

Dolder, P. C., Liechti, M. E., & Rentsch, K. M. | Analytical and bioanalytical chemistry | 27 December 2014

Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression

Drewniany, E., Han, J., Hancock, C., Jones, R. L., Lim, J., Nemat Gorgani, N., ... & Raffa, R. B. | Journal of Clinical Pharmacy and Therapeutics | 26 December 2014

Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues

Riley, A. P., Groer, C. E., Young, D., Ewald, A. W., Kivell, B. M., & Prisinzano, T. E. | Journal of medicinal chemistry | 26 December 2014

Ascending-dose study of noribogaine in healthy volunteers: Pharmacokinetics, pharmacodynamics, safety, and tolerability

Glue, P., Lockhart, M., Lam, F., Hung, N., Hung, C. T., & Friedhoff, L. | The Journal of Clinical Pharmacology | 22 December 2014

Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial

Murrough, J. W., Burdick, K. E., Levitch, C. F., Perez, A. M., Brallier, J. W., Chang, L. C., ... & Iosifescu, D. V. | Neuropsychopharmacology | 17 December 2014

Medical Drug or Shamanic Power Plant: The Uses of Kambô in Brazil

Labate, B. C., & Lima, E. C. D. | Revista do núcleo de antropologia urbana da USP | December 2014

Conformational, spectroscopic and nonlinear optical properties of biologically active N,N-dimethyltryptamine molecule: A theoretical study

Öner, N., Tamer, Ö., Avcı, D., & Atalay, Y. | Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy | 10 December 2014

Nitrous Oxide for Treatment-Resistant Major Depression: a Proof-of-Concept Trial

Nagele, P., Duma, A., Kopec, M., Gebara, M. A., Parsoei, A., Walker, M., ... & Conway, C. | Biological Psychiatry | 9 December 2014

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects

Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., ... & Liechti, M. E. | Biological psychiatry | 29 November 2014

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression

Ionescu, D. F., Luckenbaugh, D. A., Niciu, M. J., Richards, E. M., & Zarate, C. A. | Bipolar disorders | 14 November 2014

Ketamine and other potential glutamate antidepressants

Dutta, A., McKie, S., & Deakin, J. W. | Psychiatry research | 12 November 2014

Psilocybin and Obsessive Compulsive Disorder

Wilcox, J. A. | Journal of psychoactive drugs | 11 November 2014

LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects

Gasser, P., Kirchner, K., & Passie, T. | Journal of Psychopharmacology | 11 November 2014

Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety

Ballard, E. D., Ionescu, D. F., Voort, J. L. V., Niciu, M. J., Richards, E. M., Luckenbaugh, D. A., ... & Zarate, C. A. | Journal of psychiatric research | November 2014

Effects of ecstasy on cooperative behaviour and perception of trustworthiness: A naturalistic study

Stewart, L. H., Ferguson, B., Morgan, C. J. A., Swaboda, N., Jones, L., Fenton, R., ... & Curran, H. V. | Psychopharmacology | November 2014

M1 and M2 Muscarinic Receptor Subtypes Regulate Antidepressant-Like Effects of the Rapidly Acting Antidepressant Scopolamine

Witkin, J. M., Overshiner, C., Li, X., Catlow, J. T., Wishart, G. N., Schober, D. A., ... & Felder, C. C. | Journal of Pharmacology and Experimental Therapeutics | November 2014

Synesthesias in the context of hallucinogen-induced persistent perception disorder following the use of lsd

Neven, A., & Blom, J. D. | Tijdschrift voor psychiatrie | November 2014

Harmine mediated neuroprotection via evaluation of glutamate transporter 1 in a rat model of global cerebral ischemia.

Sun, P., Zhang, S., Li, Y., & Wang, L. | Neuroscience letters | 7 November 2014

Dictyonema huaorani (Agaricales: Hygrophoraceae), a new lichenized basidiomycete from Amazonian Ecuador with presumed hallucinogenic properties

Schmull, M., Dal-Forno, M., Lücking, R., Cao, S., Clardy, J., & Lawrey, J. D. | The Bryologist | 7 November 2014

Toxicities Associated With NBOMe Ingestion—A Novel Class of Potent Hallucinogens: A Review of the Literature

Suzuki, J., Dekker, M. A., Valenti, E. S., Cruz, F. A. A., Correa, A. M., Poklis, J. L., & Poklis, A. | Psychosomatics | 6 November 2014

Immunological Effects of Ayahuasca in Humans

dos Santos, R. G. (2014) | Journal of psychoactive drugs | 3 November 2014

On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis

Grammenos, D., & Barker, S. A. | Journal of Neural Transmission | 2 November 2014

Single Ketamine Infusion and Neurocognitive Performance in Bipolar Depression

Permoda-Osip, A., Kisielewski, J., Bartkowska-Sniatkowska, A., & Rybakowski, J. K. | Pharmacopsychiatry | 27 October 2014

Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats

Sakashita, Y., Abe, K., Katagiri, N., Kambe, T., Saitoh, T., Utsunomiya, I., ... & Taguchi, K. | Biological and Pharmaceutical Bulletin | 24 October 2014

Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?

Sanacora, G., & Schatzberg, A. F. | Neuropsychopharmacology | 22 October 2014

Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics

Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. | Medicine | 17 October 2014

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression

Lally, N., Nugent, A. C., Luckenbaugh, D. A., Ameli, R., Roiser, J. P., & Zarate, C. A. | Translational psychiatry | 14 October 2014

A functional selectivity mechanism at the serotonin-2A GPCR involves ligand-dependent conformations of intracellular loop 2

Perez-Aguilar, J. M., Shan, J., LeVine, M. V., Khelashvili, G., & Weinstein, H. | Journal of the American Chemical Society | October 2014

Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor

Polepally, P. R., Setola, V., Vardy, E., Roth, B. L., Mosier, P. D., & Zjawiony, J. | Planta Medica | 6 October 2014

Treating drug dependence with the aid of ibogaine: A retrospective study

Schenberg, E.E., de Castro Comis, M.A., Rasmussen Chaves, B. & da Silveira, D. X. | Journal of Psychopharmacology | 29 September 2014

Back to the future: A return to psychedelic treatment models for addiction

Hendricks, P. S. | Journal of Psychopharmacology | 24 September 2014

LSD enhances suggestibility in healthy volunteers

Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., Bolstridge, M., Feilding, A. & Nutt, D. J. | Psychopharmacology | 23 September 2014

The role of ketamine in treatment-resistant depression: a systematic review

Serafini, G., H Howland, R., Rovedi, F., Girardi, P., & Amore, M. | Current neuropharmacology | 12 September 2014

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. | Journal of Psychopharmacology | 11 September 2014

Acute effects of MDMA on autonomic cardiac activity and their relation to subjective prosocial and stimulant effects

Clark, C. M., Frye, C. G., Wardle, M. C., Norman, G. J., & Wit, H. | Psychophysiology | 10 September 2014

Blood d-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine

Hashimoto, K. | Psychopharmacology | 5 September 2014

Ketamine safety and tolerability in clinical trials for treatment-resistant depression

Wan, L. B., Levitch, C. F., Perez, A. M., Brallier, J. W., Iosifescu, D. V., Chang, L. C., ... & Murrough, J. W. | The Journal of clinical psychiatry | 2 September 2014

Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells

Szabo, A., Kovacs, A., Frecska, E., & Rajnavolgyi, E. | PloS ONE | 29 August 2014

Potential applications for sigma receptor ligands in cancer diagnosis and therapy

van Waarde, A., Rybczynska, A. A., Ramakrishnan, N. K., Ishiwata, K., Elsinga, P. H., & Dierckx, R. A. | Biochimica et Biophysica Acta (BBA)-Biomembranes | 27 August 2014

By its fruits? Mystical and visionary states of consciousness occasioned by entheogens

Hummel, L. | Zygon: Journal of Religion and Science | 26 August 2014

Entheogens in a religious context: The case of the Santo Daime religious tradition

Barnard, G. W | Zygon: Journal of Religion and Science | 26 August 2014

Here and now: Discovering the sacred with entheogens

Richards, W. A. | Zygon: Journal of Religion and Science | 26 August 2014

Entheogens, Mysticism, and Neuroscience

Cole-Turner, R. | Zygon: Journal of Religion and Science | 26 August 2014

Determination of muscimol and ibotenic acid in mushrooms of Amanitaceae by capillary electrophoresis.

Poliwoda, A., Zielińska, K., Halama, M., & Wieczorek, P. P. | Electrophoresis | 18 August 2014

Iboga-Type Alkaloids from Ervatamia officinalis

Tang, B. Q., Wang, W. J., Huang, X. J., Li, G. Q., Wang, L., Jiang, R. W., ... & Ye, W. C. | Journal of natural products | 5 August 2014

Does the Nervous System Have an Intrinsic Archaic Language? Entoptic Images and Phosphenes

Sayin, H. U. | Neuroquantology | 2 August 2014

Ketamine administration in depressive disorders: a systematic review and meta-analysis

Fond, G., Loundou, A., Rabu, C., Macgregor, A., Lançon, C., Brittner, M. ... Boyer, L. | Psychopharmacology | 20 July 2014

Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

Halberstadt, A. L. | Behavioural Brain Research | 15 July 2014

The Effects of Ayahuasca Ritual Participation on Gay and Lesbian Identity

Cavnar, C. | Journal of psychoactive drugs | 14 July 2014

The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice

Carbonaro, T. M., Eshleman, A. J., Forster, M. J., Cheng, K., Rice, K. C., & Gatch, M. B. | Psychopharmacology | 3 July 2014

Enhanced repertoire of brain dynamical states during the psychedelic experience

Tagliazucchi, E., Carhart-Harris, R. L., Leech, R., Nutt, D., & Chialvo, D. R. | Human Brain Mapping | 2 July 2014

(R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function

Paul, R. K., Singh, N. S., Khadeer, M., Moaddel, R., Sanghvi, M., Green, C. E., ... & Wainer, I. W. | The Journal of the American Society of Anesthesiologists | 1 July 2014

Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study

Garcia-Romeu, A. P., Johnson, M. W., & Griffiths, R. R. | Drug & Alcohol Dependence | 1 July 2014

Harmine for catatonic schizophrenia. A forgotten experiment

Hostiuc, S., Buda, O., & Ion, D. A. | Schizophrenia research | June 30 2014

The Consumption of Psychoactive Plants in Ancient Global and Anatolian Cultures During Religious Rituals: The Roots of the Eruption of Mythological Figures and Common Symbols in Religions and Myths

Sayin, H. U. | NeuroQuantology | 12 June 2014

Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder

Feder, A., Parides, M. K., Murrough, J. W., Perez, A. M., Morgan, J. E., Saxena, S., ... & Charney, D. S. | JAMA psychiatry | June 2014

Psychoactive Plants: A Neglected Area of Ethnobotanical Research in Southern Africa (Review)

Jean-Francois, S. | STUDIES ON ETHNO-MEDICINE | June 2014

Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases

Litjens, R. P., Brunt, T. M., Alderliefste, G. J., & Westerink, R. H. | European Neuropsychopharmacology |

Indigenous healing practice: Opening a discussion

Prue, R., & Voss, R. W. | Journal of Pastoral Care & Counseling | June 2014

Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?

Rolland, B., Jardri, R., Amad, A., Thomas, P., Cottencin, O., & Bordet, R. | Biomed Research International | 4 June 2014

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers

Roseman, L., Leech, R., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. | Frontiers in Human Neuroscience | 27 May 2014

The effect of psilocin on memory acquisition, retrieval, and consolidation in the rat

Rambousek, L., Palenicek, T., Vales, K., & Stuchlik, A. | Frontiers in Behavioral Neuroscience | 16 May 2014

Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes

Blough, B. E., Landavazo, A., Decker, A. M., Partilla, J. S., Baumann, M. H,. & Rothman, R. B. | Psychopharmacology | 7 May 2014

Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling

Buchborn, T., Schröder, H., Höllt, V., & Grecksch, G. | Journal of Psychopharmacology | 30 April 2014

Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers

Kraehenmann, R., Preller, K. H., Scheidegger, M., Pokorny, T., Bosch, O. G., Seifritz, E., & Vollenwieder, F. X. | Biological Psychiatry | 26 April 2014

A window into the intoxicated mind? Speech as an index of psychoactive drug effects.

Bedi, G., Cecchi, G. A., Slezak, D. F., Carrillo, F., Sigman, M., & de Wit, H. | Neuropsychopharmacology | 3 April 2014

Hallucinogens causing seizures? A case report of the synthetic amphetamine 2,5-dimethoxy-4-chloroamphetamine

Burish, M. J., Thoren, K. L., Madou, M., Toossi, S., & Shah, M. | The Neurohospitalist | 1 April 2014

From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs

Morris, H., & Wallach, J. | Drug testing and analysis | 26 March 2014

Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles

Baumeister, D., Barnes, G., Giaroli, G., & Tracy, D. | Therapeutic Advances in Psychopharmacology | 17 March 2014

PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program

Greer, G. R., Grob, C. S., & Halberstadt, A. L. | Journal of Psychoactive Drugs | 11 March 2014

Therapeutic Effects of Ritual Ayahuasca Use in the Treatment of Substance Dependence—Qualitative Results

Loizaga-Velder, A., & Verres, R. | Journal of Psychoactive Drugs | 11 March 2014

Why Psychiatry Needs Psychedelics and Psychedelics Need Psychiatry

Sessa, B. | Journal of Psychoactive Drugs | 11 March 2014

MDMA and the “Ecstasy Paradigm”

Cole, J. C. | Journal of Psychoactive Drugs | 11 March 2014

The Potential Dangers of Using MDMA for Psychotherapy

Parrott, A. C. | Journal of Psychoactive Drugs | 11 March 2014

History and Future of the Multidisciplinary Association for Psychedelic Studies (MAPS)

Emerson, A., Ponté, L., Jerome, L., & Doblin, R. | Journal of Psychoactive Drugs | 11 March 2014

The Heffter Research Institute: Past and Hopeful Future

Nichols, D. E. | Journal of Psychoactive Drugs | 11 March 2014

Self-Experimentations with Psychedelics Among Mental Health Professionals: LSD in the Former Czechoslovakia

Winkler, P., & Csémy, L. | Journal of Psychoactive Drugs | 11 March 2014

From Hofmann to the Haight Ashbury, and into the Future: The Past and Potential of Lysergic Acid Diethlyamide

Smith, D. E., Raswyck, G. E., & Leigh Dickerson Davidson, L. | Journal of Psychoactive Drugs | 11 March 2014

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. | The Journal of Nervous and Mental Disease | 3 March 2014

Therapeutic infusions of ketamine: Do the psychoactive effects matter?

Dakwar, E., Anerella, C., Hart, C. L., Levin, F. R., Mathew, S. J., & Nunes, E. V. | Drug and alcohol dependence | 18 Feb 2014

Do the dissociative side effects of ketamine mediate its antidepressant effects?

Luckenbaugh, D. A., Niciu, M. J., Ionescu, D. F., Nolan, N. M., Richards, E. M., Brutsche, N. E., ... & Zarate, C. A. | Journal of affective disorders | 18 Feb 2014

MDMA decreases the effects of simulated social rejection

Frye, C. G., Wardle, M. C., Norman, G. J., & de Wit, H. | Pharmacology Biochemistry and Behavior | February 2014

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. | Frontiers in Human Neuroscience | 3 February 2014

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labelling and Blood Oxygen Level-Dependent Resting-State Functional Connectivity

Carhart-Harris, R. L., Murphy, K., Leech, R., Erritzoe, D., Wall, M. B., Ferguson, B., ... Nutt, D. J. | Biological Psychiatry | 10 January 2014

Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision

Hendricks, P. S., Clark, C. B., Johnson, M. W., Fontaine, K. R., & Cropsey, K. L. | Journal of Psychopharmacology | 2 January 2014

Labate & Coutinho – “My Grandfather Served Ayahuasca to Mestre Irineu”: Reflections on the Entrance of Indigenous Peoples into the Urban Circuit of Ayahuasca Consumption in Brazil

Labate, B. & Coutinho, T. | Curare | 1 January 2014

Peyote as Medicin: an Examination of Therapeutic Factors that Contribute to Healing

Feeney, K.| Curare | 1 January 2014

IJTS Special Topic Section: Ketamine ● The Transformative Power of Ketamine: Psychedelic States and a Personal History of Transformation

Wolfson, P. E. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Ketamine (IM) Assisted Psychotherapy (KAP): A Model for Informed Consent

Wolfson, P. E. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Ethnographic Accounts of Ketamine Explorations in Psychedelic Culture

Ring, K., Metzner, R., & Wolfson, P. E. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Psychedelic Experiential Pharmacology: Pioneering Clinical Explorations with Salvador Roquet

Wolfson, P. E. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Regarding the Transpersonal Nature of Ketamine Therapy: An Approach to the Work

Becker, J. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Making Ketamine Work in the Long Run

Early, T. S. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Ketamine Psychedelic Psychotherapy: Focus on its Pharmacology, Phenomenology, and Clinical Applications

Kolp, E., Krupitsky, E., Sylvester, M., Kolp, A., Friedman, H. L., Jansen, K., & Young, M. S. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Ketamine for Depression: A Mixed-Methods Study

Wolfson, P. E. | International Journal of Transpersonal Studies | 2014

LSD Flashbacks – The Appearance of New Visual Imagery Not Experienced During Initial Intoxication: Two Case Reports.

Lerner, A. G., Goodman, C., Rudinski, D., & Lev-Ran, S. | Isr J Psychiatry Relat Sci | 1 January 2014

Flashbacks and HPPD: A Clinical-oriented Concise Review.

Rudinski, D., Bor, O., & Goodman, C. | The Israel journal of psychiatry and related sciences | 1 January 2014

IJTS Special Topic Section: Ketamine ● Ketamine and Depression: A Review

Ryan, W. C., Marta, C. J., & Koek, R. J. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Ketamine—Its History, Uses, Pharmacology, Therapeutic Practice, and an Exploration of its Potential as a Novel Treatment for Depression

Wolfson, P.E. | The International Journal of Transpersonal Studies | 2014

Psilocybin – Summary of knowledge and new perspectives

Tylš, F., Páleníček, T., & Horáček, J. | European Neuropsychopharmacology | 17 December 2013

Ibogaine: a review

Alper, K. R. | The alkaloids: Chemistry and Biology | 4 December 2013

Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample

Winstock, A. R., Kaar, S., & Borschmann, R. | Journal of Psychopharmacology | 27 November 2013

Reviewing the ketamine model for schizophrenia

Frohlich, J., & van Horn, J. D. | Journal of Psychopharmacology | 20 November 2013

Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy

Caddy, C., Giaroli, G., White, T. P., Sukhwinder, S. S. & Tracy, D. K. | Therapeutic Advances in Psychopharmacology | 22 October 2013

Serotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia

Brogaard, B. | Frontiers in Human Neuroscience | 21 October 2013

Ayahuasca and cancer treatment

Schenberg, E. E. | SAGE Open Medicine | 21 October 2013

The induction of synaesthesia with chemical agents: a systematic review

Luke, D. P., & Terhune, D. B. | Frontiers in Psychology | 17 October 2013

Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review

de Kleine, R. A., Rothbaum, B. O., & van Minnen, A. | European Journal of Psychotraumatoly | 17 October 2013

Effect of Iboga Alkaloids on µ-Opioid Receptor-Coupled G Protein Activation

Antonio, T., Childers, S. R., Rothman, R. B., Dersch, C. M., King, C., Kuehne, M., ... & Alper, K. | PloS ONE | 16 October 2013

MDMA enhances emotional empathy and prosocial behavior

Hysek, C. M., Schmid, Y., Simmler, L. D., Domes, G., Heinrichs, M., Eisenegger, C., ... Liechti, M. E. | Social Cognitive & Affective Neuroscience | 4 October 2013

Effective interventions in the problematic use of alcohol and other drugs

Lefio L. Á., Villarroel S.R., Rebolledo C., Zamorano P., & Rivas K. | Revista Panamericana de Salud Pública | 1 October 2013

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., ... Mathew, S. J. | American Journal of Psychiatry | October 2013

Ketamine for Treatment-Resistant Depression: Ready or Not for Clinical Use?

Rush, A. J. | American Journal of Psychiatry | 1 October 2013

Self-Medication of LSD and MDMA to Treat Mental Disorders: A Case Series

Sessa, B. | The Journal of Alternative Medicine Research | September 2013

Broadband cortical desynchronization underlies the human psychedelic state

Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J., Brookes, M. J., Williams, T. M., Errtizoe, D., ... & Feilding, A. | The Journal of Neuroscience | 18 September 2013

A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment

Burdick, B. V., & Adinoff, B. | The American Journal of Drug and Alcohol Abuse | September 2013

Psychedelics and Mental Health: A Population Study

Krebs, T. S., & Johansen, P. Ø. | PLoS ONE | 19 August 2013

Phylogenetic inference and trait evolution of the psychedelic mushroom genus Psilocybe sensu lato (Agaricales)

Ramírez-Cruz, V. Guzmán, G., Villalobos-Arámbula, A. R., Rodríguez, A., Matheny, P. B., Sánchez-García, M., & Guzmán-Dávalos, L. | Botany | 6 August 2013

Methoxetamine (MXE) – A Phenomenological Study of Experiences Induced by a “Legal High” from the Internet

Kjellgren, A., & Jonsson, K. | Journal of psychoactive drugs | 2 August 2013

Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users.

Bouso, J. C., Fábregas, J. M., Antonijoan, R. M., Rodríguez-Fornells, A., & Riba, J. | Psychopharmacology | 21 June 2013

Effects of Schedule I drug laws on neuroscience research and treatment innovation

Nutt, D. J., King, L. A., & Nichols, D. E.| Nature Reviews Neuroscience | 12 June 2013

2C or not 2C: phenethylamine designer drug review

Dean, B. V., Stellpflug, S. J., Burnett, A. M., & Engebretsen, K. M. | Journal of Medical Toxicology | 9 June 2013

A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity

Frecska, E., Szabo, A., Winkelman, M. J., Luna, L. E., & McKenna, D. J. | Journal of Neural Transmission | 26 April 2013

NMDA Receptor Antagonists for Treatment of Depression

Ates-Alagoz, Z., & Adejare, A. | Pharmaceuticals | 3 April 2013

The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor

Roth, B. L., Gibbons, S., Arunotayanun, W., Huang, X. P., Setola, V., Treble, R., & Iversen, L. | PLoS One | 19 March 2013

Hallucinogen persisting perception disorder: what do we know after 50 years?

Halpern, J. H., & Harrison, G. P. Jr. | Drug and Alcohol Dependence | 1 March 2013

Studying the Effects of Classic Hallucinogens in the Treatment of Alcoholism: Rationale, Methodology, and Current Research with Psilocybin

Bogenschutz, M. P. | Current Drug Abuse Reviews | 1 March 2013

Ibogaine in the Treatment of Substance Dependence

Brown, T. K. | Current Drug Abuse Reviews | 1 March 2013

Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada

Thomas, G., Lucas, P., Capler, N.R., Tupper, K. W., & Martin, G. | Current Drug Abuse Reviews | 1 March 2013

Salvia divinorum: A Psychopharmacological Riddle and a Mind-Body Prospect

Diaz, J-L. | Current Drug Abuse Reviews | 1 March 2013

Can MDMA Play a Role in the Treatment of Substance Abuse?

Jerome, L, Schuster, S., & Yazar-Klosinski, B. B. | Current Drug Abuse Reviews | 1 March 2013

Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology

dos Santos, R. G. | Journal of Psychoactive Drugs | 28 February 2013

Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors

Kometer, M., Schmidt, A., Bachmann, R., Studerus, E., Seifritz, E., & Vollenweider, F. X. | Biological Psychiatry | 19 December 2012

Durability of improvement in posttraumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

Mithoefer, M.C., Wagner, M. T., Mithoefer, A. T., Jerome, L., Martin, S. F., Yazar-Klosinski, B., ... Doblin, R. | Journal of Psychopharmacology | 20 November 2012

A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)

Oehen, P., Traber, R., Widmer, V., & Schnyder, U. | Journal of Psychopharmacology | 31 October 2012

Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis

Carhart-Harris, R. L., Leech, R., Erritzoe, D., Williams, T. M., Stone, J. M., Evans, J., .... Nutt, D. J. | Schizophrenia Bulletin | 8 October 2012

Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study

Bouso, J. C, González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P. C. R., ... Riba, J. | PLoS ONE | 8 August 2012

The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions

Schmidt, A., Kometer, M., Bachmann, R., Seifritz, E., & Vollenweider, F.X. | Psychopharmacology | 27 July 2012

Research on psychedelic substances

Brandt, S. D., & Passie, T. | Drug testing and analysis | 06 Jul 2012

Health status of ayahuasca users.

Barbosa, P. C. R., Mizumoto, S., Bogenschutz, M. P., & Strassman, R. J. | Drug testing and analysis | 4 July 2012

Quantitative Analysis of Narrative Reports of Psychedelic Drugs

Coyle, J. R., Presti, D. E., Baggott, M. J. | 1 June 2012

Analytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices

Gaujac, A., Navickiene, S., Collins, M. I., Brandt, S. D., & Andrade, J. B. | Drug testing and analysis | 11 May 2012

Genuine and drug-induced synesthesia: a comparison

Sinke, C., Halpern, J. H., Zedler, M., Neufeld, J., Emrich, H. M., & Passie, T. | Consciousness and cognition | 21 April 2012

Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca

Riba, J., McIlhenny, E. H., Valle, M., Bouso, J. C., & Barker, S. A. | Drug testing and analysis | 19 April 2012

Special Ayahuasca Issue Introduction: Toward a Multidisciplinary Approach to Ayahuasca Studies

Beyer, S. V. | Anthropology of Consciousness | 14 March 2012

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

Krebs, T. S., & Johansen, P. Ø. | Journal of Psychopharmacology | 8 March 2012

Implications for psychedelic-assisted psychotherapy: Functional magnetic resonance imaging study with psilocybin

Carhart-Harris, R. L., Leech, R., Williams, T. M., Erritzoe, D., Abbasi, N., Bargiotas, T., ... & Wise, R. G. | The British Journal of Psychiatry | 1 March 2012

A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010

Barker, S. A., McIlhenny, E. H., Strassman, R. | Drug Testing and Analysis | 28 February 2012

Replication of Ketamine’s Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial

Zarate Jr., A., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., ... Luckenbaugh, D. A. | Biological Psychiatry | 31 January 2012

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., ... Nutt, D. J. | Proceedings of the National Academy of Sciences of the United States of America | January 2012

Could MDMA be useful in the treatment of post-traumatic stress disorder?

Sessa, B. | Progress in Neurology and Psychiatry | 15 December 2011

Drugs as instruments: A new framework for non-addictive psychoactive drug use

Müller, C. P., & Schumann, G.| Behavioral and Brain Sciences | 10 November 2011

Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

Shen, H. W. , Jiang, X. L., Winter, J. C., Yu, A. M.| Current Drug Metabolism | 1 October 2011

Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers

Quednow, B. B., Kometer, M., Geyerand, M. A., & Vollenweider, F. X. | Neuropsychopharmacology | 28 September 2011

Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness

MacLean, K. A., Johnson, M. W., & Griffiths, R. R. | Journal of Psychopharmacology | 28 September 2011

Revisiting Wasson’s Soma: Exploring the Effects of Preparation on the Chemistry of Amanita Muscaria

Feeney, K. | Journal of psychoactive drugs | 20 Sep 2011

Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion

de Aurojo, D. B., Ribeiro, S., Cecchi, G. A., Carvalho, F. M., Sanchez, T. A., Pinto, J. P., ... Santos, A. C. | Human Brain Mapping | 16 September 2011

Psychedelic Experience as a Heuristic Tool for Exploring the Mind and the Brain

Alyushin, A. | NeuroQuantology | September 2011

Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence

Krupitsky, E. M., Burakov, A. M., Dunaevsky, I. V., Romanova, T. N., Slavina, T. Y., & Grinenko, A. Y. | Journal of psychoactive drugs | 08 Sep 2011

Reassessing the cultural and psychopharmacological significance of Banisteriopsis caapi: preparation, classification and use among the Piaroa of Southern Venezuela

Rodd, R. | Journal of psychoactive drugs | 8 September 2011

Combating substance abuse with ibogaine: pre- and posttreatment recommendations and an example of successive model fitting analyses

Hittner, J. B., & Quello, S. B. | Journal of Psychoactive Drugs | 7 September 2011

Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis

Callaway, J. C., Brito, G. S., & Neves, E. S. | Journal of psychoactive drugs | 7 September 2011

Bringing Ayahuasca to the Clinical Research Laboratory

Riba, J., & Barbanoj, M. J. | Journal of Psychoactive Drugs | 7 September 2011

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

Larkin, G. L., & Beautrais, A. L. | International Journal of Neuropsychopharmacology | 1 September 2011

Heaven and Hell—A Phenomenological Study of Recreational Use of 4-HO-MET in Sweden

Kjellgren, A., & Soussan, C.| Journal of Psychoactive Drugs | 29 August 2011

Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain

Réus, G. Z., Stringari, R. B., Ribeiro, K. F., Ferraro, A. K., Vitto, M. F., Cesconetto, P., ... Quevedo, J. | Behavioural Brain Research, 221 | 1 August 2011

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. | Psychopharmacology | 15 June 2011

In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin 2A Receptor Binding in MDMA and Hallucinogen Users

Erritzoe, D., Frokjaer, V. G., Holst, K. K., Christoffersen, M., Johansen, S. S., Svarer, C., ... Knudsen, G. M. | Archives of General Psychiatry | 6 June 2011

β-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer’s Disease-Related Sites

Frost, D., Meechoovet, B., Wang, T., Gately, S., Giorgetti, M., Shcherbakova, I., & Dunckley, T. | PLoS One | 6 May 2011

Ayahuasca, Entheogenic Education & Public Policy

Tupper, K. W. | (Doctoral dissertation, University of British Columbia) | 18 April 2011

Consumption of Ayahuasca by Children and Pregnant Women: Medical Controversies and Religious Perspectives

Labate, B. C. | Journal of Psychoactive Drugs | 8 April 2011

Harm potential of magic mushroom use: A review

van Amsterdam, J., Opperhuizen, A., & van den Brink, W. | Regulatory toxicology and pharmacology | 01 April 2011

The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations

Kometer, M., Cahn, B. R., Andel, D., Carter, O. L., & Vollenweider, F. X. | Biological Psychiatry | 1 March 2011

Start Your Own Religion: New York State’s Acid Churches

Lander, D. R. | The Journal of Alternative and Emergent Religions | February 2011

A Prehistoric Mural in Spain Depicting Neurotropic Psilocybe Mushrooms?

Akers, B. P., Ruiz, J. F., Piper, A., & Ruck, C. A. P. | Economic Botany | 17 February 2011

Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs

Halpern, J. H., Sherwood, A. R., Hudson, J. I., Gruber, S. Kozin, D., & Pope Jr., H. G. | Addiction | 15 February 2011

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

Halberstadt, A. L., & Geyer, M.A. | Neuropharmacology | 20 January 2011

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. | Archives of General Psychiatry | 3 January 2011

Exploring the impact of ketamine on the experience of illusory body ownership

Morgan, H. L., Turner, D. C., Corlett, P. R., Absalom, A. R., Adapa, R., Arana, F. S., ... Fletcher, P. C. | Biological Psychiatry | 1 January 2011

Characterization of behavioral and endocrine effects of LSD on zebrafish

Grossman, L., Utterback, E., Stewarta, A., Gaikwada, S., Chunga, K. M., Suciua, C., ... Kalueff, A. V. | Behavioural Brain Research, 214 | 25 December 2010

Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others

Bedia, G., Hymana, D., & de Wit, H. | Biological Psychiatry | 15 December 2010

Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial

Mendelson, J. E., Coyle, J. R., Lopez, J.C., Baggott, M. J., Flower, K., Everhart, E. T., ... Cohen, B. M. | Psychopharmacology | 8 December 2010

Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum

Johnson, M. W., Maclean, K.A., Reissig, C. R., Prisinzano, T. E., & Griffiths, R. R. | Drug and Alcohol Dependence | 3 December 2010

Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans

Baggott, M. J., Siegrist, J. D., Galloway, G. P., Robertson, L. C., Coyle, J. R., & Mendelson, J. E. | PLoS ONE | 2 December 2010

Evolution and origins of the Mazatec hallucinogenic sage, Salvia divinorum (Lamiaceae): a molecular phylogenetic approach

Jenks, A. A., Walker, J.B., Kim, S. C. | Journal of Plant Research | 2 December 2010

Ayahuasca, Salutogenesis and the Need for „Ecological“ Approaches

Friczewski, F. | NEIP | 14 November 2010

Psychobiology of Drug-Induced Religious Experience: From the Brain ‘Locus of Religion’ to Cognitive Unbinding

Nencini, P., & Grant, G. A. | Substance Use & Misuse | November 2010

Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine

McIlhenny, E. H., Riba, J., Barbanoj, M. J., Strassman, R., & Barker, S. A. | Biomedical Chromatography | 5 November 2010

Serotonin, But Not N-Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex In Vivo

Schmid, C. L., & Bohn, L. M. | The Journal of Neuroscience | 6 October 2010

Assessment of addiction severity among ritual users of ayahuasca

Fábregas, J. M., González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P. C., Riba, J., ... Bouso J. C. | Drug and Alcohol Dependence | 1 October 2010

Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague–Dawley rats

Killingera, B. A., Peeta, M. M., & Baker, L. E. | Pharmacology Biochemistry and Behavior | September 2010

Glutamatergic Model Psychoses: Prediction Error, Learning, and Inference

Corlett, P. R., Honey, G. D., Krystal, J. H., & Fletcher, P. C. | Neuropsychopharmacology Reviews | 22 September 2010

Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire

Baggott, M. J., Coyle, J. R., Erowid, E., Erowid, F., & Robertson, L. C. | Drug and alcohol dependence | 21 Sep 2010

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies

Studerus, E., Kometer, M., Hasler, F., & Vollenweider, F. X. | Journal of Psychopharmacology | 20 September 2010

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

Vollenweider, F. X., & Kometer, M. | Nature Reviews Neuroscience | September 2010

Intrahippocampal LSD accelerates learning and desensitizes the 5-HT2A receptor in the rabbit

Romano, A. G., Quinn, J. L., Li, L., Dave, K. D., Schindler, E. A., Aloyo, V. J., & Harvey, J. A. | Psychopharmacology | 9 September 2010

Dimethyltryptamine (DMT): Subjective effects and patterns of use among Australian recreational users

Cakica, V., Potkonyakb, J., & Marshalla, A. | Drug and Alcohol Dependence | 1 September 2010

Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)

Studerus, E., Gamma, A., & Vollenweider, F. X. | PLoS ONE | 31 August 2010

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

Diazgranados, N., Ibrahim, L. Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., ... Zarate Jr., Z. A. | Archives of General Psychiatry | August 2010

The safety and efficacy of ±3,4-methylenedioxymethamphetamineassisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder

Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. | Journal of Psychopharmacology | 19 July 2010

Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin

Benzenhöfer, U., & Passie, T. | Addiction | 9 July 2010

qNMR: An applicable method for the determination of dimethyltryptamine in ayahuasca, a psychoactive plant preparation

Moura, S., Carvalhoa, F. G., Rodrigues de Oliveiraa, C. D., Pintoa, E., & Yonaminea, M. | Phytochemistry | 11 June 2010

Composition, Standardization and Chemical Profiling of Banisteriopsis caapi, a Plant for the Treatment of Neurodegenerative Disorders Relevant to Parkinson’s Disease

Wang, Y. H., Samoylenko, V., Tekwani, B. L., Khan, I. A., Miller, L. S., Chaurasiya, N. D., ... & Muhammad, I. | Journal of ethnopharmacology | 21 April 2010

Ayahuasca Beyond the Amazon: the Benefits and Risks of a Spreading Tradition

Trichter, S. | The Journal of Transpersonal Psychology | 2010

The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series

Karst, M., Halpern, J. H., Bernateck, M., & Passie, T. | Cephalalgia | 26 Mar 2010

The persistence of the subjective in neuropsychopharmacology: observations of contemporary hallucinogen research

Langlitz, N. | History of Human Sciences | February 2010

Psychedelics and the Human Receptorome

Ray, T. S. | PLoS ONE | 2 February 2010

Cannabis and Ecstasy/MDMA: Empirical Measures of Creativity in Recreational Users

Jones, K. A., Blagrove, M., & Parrott, A. C. | Journal of Psychoactive Drugs | December 2009

Experiences of Encounters with Ayahuasca – “the Vine of the Soul”

Kjellgren, A., Eriksson, A., & Norlander, T. | Joumal of Psychoactive Drugs | December 2009

Ayahuasca–From Dangerous Drug to National Heritage: An Interview with Antonio A. Arantes

Labate, B. C., & Goldstein, I. | International Journal of Transpersonal Studies | 2009

LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor

Halberstadt, A. L, & Geyer, M. A. | Psychopharmacology | 25 November 2009

Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson’s disease

Samoylenko, V., Rahman, M. M., Tekwani, B. L., Tripathi, L. M., Wang, Y. H., Khan, S. I., ... & Muhammad, I. | Journal of ethnopharmacology | 30 October 2009

Changes in Spirituality Among Ayahuasca Ceremony Novice Participants

Trichter, S., Klimo, J., & Krippner, S. | Journal of Psychoactive Drugs | 23 June 2009

The Neurochemical Effects of Harmine in Animal Models of Depression

Fortunato, J. J. | PhD thesis | 2009

When the Endogenous Hallucinogenic Trace Amine N,N-Dimethyltryptamine Meets the Sigma-1 Receptor

Su, T., Hayashi, T., & Vaupel, D. B. | Science Signaling | 10 March 2009

How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale

Johansen, P. Ø., & Krebs, T. S.| Journal of Psychopharmacology | 9 March 2009

Endogenous hallucinogens as ligands of the trace amine receptors: A possible role in sensory perception

Wallach, J. V. | Medical Hypotheses | January 2009

Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage

Pires, A. P. S., De Oliveira, C. D. R., Moura, S., Dörr, F. A., Silva, W. A. E., & Yonamine, M. | Phytochemical Analysis | 12 January 2009

Unauthorized Research on Cluster Headache

Sewell, R. A. | The Entheogen Review | December 2008

The Pharmacology of Lysergic Acid Diethylamide: A Review

Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. | CNS Neuroscience & Therapeutics | 11 November 2008

Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines

Winter, J. C. | Psychopharmacology | 1 November 2008

The Phenomenology and Potential Religious Import of States of Consciousness Facilitated by Psilocybin

Richards, W. A. | Archive for the Psychology of Religion | October 2008

Ayahuasca and Spiritual Crisis: Liminality as Space for Personal Growth

Lewis, S. E. | Anthropology of Consciousness | 16 September 2008

Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament

Halpern, J. H., Sherwood, A. R., Passie, T., Blackwell, K. C., & Ruttenber, A. J. | Medical Science Monitor | 01 Aug 2008

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

Griffiths, R. R., Richards, W. A., Johnson, M. W., McCann U. D., & Jesse, R. | Journal of Psychopharmacology | 1 July 2008

Human hallucinogen research: guidelines for safety

Johnson, M. W., Richards, W. A., & Griffiths, R. R. | Journal of Psychopharmacology | 1 July 2008

‘Hybrid’ benzofuran-benzopyran congeners as rigid analogs of hallucinogenic phenethylamines

Schultz, D. M., Prescher, J. A., Kidd, S., Marona-Lewicka, D., Nichols, D. E., & Montea, A. | Bioorganic & Medicinal Chemistry | 1 June 2008

[Hallucinogen-induced psychological disorders]

Hermle, L., Kovar, K. A., Hewer, W., & Ruchsow, M. | Fortschritte der Neurologie-Psychiatrie | 1 June 2008

Selective 5-HT2A agonist hallucinogens: A review of pharmacological interaction and corollary perceptual effects

Kent, J. | Beta Review | 23 May 2008

Effects of varied doses of psilocybin on time interval reproduction in human subjects

Wackermann, J., Wittmann, M., Hasler, F., & Vollenweider, F. X. | Neuroscience letters | 11 Apr 2008

The correlation between ketamine and posttraumatic stress disorder in burned service members

McGhee, L. L., Maani, C. V., Garza, T. H., Gaylord, K. M., & Black, I. H. | Journal of Trauma and Acute Care Surgery | February 2008

The behavioral pharmacology of hallucinogens

Fantegrossi, W. E., Murnane, K. S., & Reissig, C. J. | Biochemical Pharmacology | 1 January 2008

Comparative potencies of MDMA analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines

Montgomery, T., Buon, C., Eibauer, S., Guiry, P. J., Keenan, A.K., & McBean, G. J. | British Journal of Pharmacology | December 2007

Chronic Phenethylamine Hallucinogen Treatment Alters Behavioral Sensitivity to a Metabotropic Glutamate 2/3 Receptor Agonist

Benneyworth, M. A., Smith, R. L., & Sanders-Bush, E. | Neuropsychopharmacology | 24 October 2007

Land of the Living Sky with Diamonds: A Place for Radical Psychiatry?

Dyck, E. | Journal of Canadian Studies | 1 October 2007

Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans

Carter, O. L., Hasler, F., Pettigrew, J. D., Wallis, G. M., Liu, G. B., & Vollenweider, F. X. | Psychopharmacology | 14 September 2007

Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members

Santos, R. G., Landeira-Fernandez, J., Strassman, R. J., Motta, V., & Cruz, A. P. M. | Journal of Ethnopharmacology | 27 July 2007

Psilocybin-induced stimulus control in the rat

Winter, J. C., Rice, K. C., Amorosi, D. J., & Rabin, R. A. | Pharmacology Biochemistry and Behavior | 22 June 2007

Brave New World versus Island — Utopian and Dystopian Views on Psychopharmacology

Schermer, M. H. N. | Medicine, Health Care and Philosophy | 08 May 2007

The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval

Vollenweider, F. X, Csomor, P. A., Knappe, B., Geyer, M. A., & Quednow, B. B. | Neuropsychopharmacology | 14 February 2007

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.

González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., ... & Gingrich, J. A. | Neuron | 1 February 2007

Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder

Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. | Journal of Clinical Psychiatry | November 2006

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

Griffiths, R. R., Richards, W. A., & McCann, U. | Psychopharmacology | 7 July 2006

Response of cluster headache to psilocybin and LSD

Sewell, R. A., Halpern, J. H., & Pope, Jr., H. G. | Neurology | 27 June 2006

Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected

Kuypers, K. P., & Ramaekers, J. G. | Psychopharmacology | 1 March 2006

Mechanisms of antiaddictive actions of ibogaine

Glick, S. D., & Maisonneuve, I. S. | Annals of the New York Academy of Sciences | 7 February 2006

Hallucinogenic botanicals of America: A growing need for focused drug education and research

Halpern, J. H., & Sewell, R. A. | Life sciences | 22 Dec 2005

Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine

Kuypers, K. P., & Ramaekers, J. G. | Journal of Psychopharmacology | 1 November 2005

Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors

Carter, O. L., Burr, D. C., Pettigrew, J. D., Wallis, G. M., Hasler, F., & Vollenweider, F. X. | Journal of Cognitive neuroscience | 1 October 2005

Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers

Gouzoulis-Mayfrank, E., Heekeren, K., Neukirch, A., Stoll, M., Stock, C., Obradovic, M., & Kovar, K. A. | Pharmacopsychiatry | 2005

Hallucinogen persisting perception disorder after psilocybin consumption: a case study.

Espiard, M. L., Lecardeur, L., Abadie, P., Halbecq, I., & Dollfus, S. | European psychiatry | 1 August 2005

Effects of peritraumatic ketamine medication on early and sustained posttraumatic stress symptoms in moderately injured accident victims

Schönenberg, M., Reichwald, U., Domes, G., Badke, A., & Hautzinger, M. | Psychopharmacology | 13 July 2005

Effects of different subanesthetic doses of (S)-ketamine on neuropsychology, psychopathology, and state of consciousness in man

Passie, T., Karst, M., Wiese, B., Emrich, H. M., & Schneider, U. | Neuropsychobiology | 12 May 2005

Ecstasy (MDMA) mimics the post-orgasmic state: impairment of sexual drive and function during acute MDMA-effects may be due to increased prolactin secretion

Passie, T., Hartmann, U., Schneider, U., Emrich, H. M., & Krüger, T. H. | Medical hypotheses | 09 Nov 2004

Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine

Jacob, M. S., & Presti, D. E. | Medical Hypotheses | 4 November 2004

Psychotherapeutic interventions at the end of life: a focus on meaning and spirituality

Breitbart, W., Gibson, C., Poppito, S. R., & Berg, A. | Canadian Journal of Psychiatry | June 2004

Hallucinogens and dissociative agents naturally growing in the United States

Halpern, J. H. | Pharmacology & therapeutics | 1 May 2004

Hallucinogens

Nichols, D. E. | Pharmacology & therapeutics | 28 January 2004

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebocontrolled dose-effect study

Hasler, F., Grimberg, U., Benz, M. A., Huber, T., & Vollenweider, F. X. | Psychopharmacology | 13 November 2003

Hallucinogens: An update

Halpern, J. H. | Current psychiatry reports | 01 Sep 2003

Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features.

Lerner, A. G., Gelkopf, M., Skladman, I., Rudinski, D., Nachshon, H., & Bleich, A. | International clinical psychopharmacology | 1 March 2003

Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia

Umbricht, D., Vollenweider, F. X., Schmid, L., Gruebel, C., Skrabo, A., Huber, T., & Koller, R. | Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology | 1 Februari 2003

Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man

Passie, T., Karst, M., Borsutzky, M., Wiese, B., Emrich, H. M., & Schneider, U. | Journal of Psychopharmacology | 1 January 2003

Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up

Krupitsky, E., Burakov, A., Romanova, T., Dunaevsky, I., Strassman, R., & Grinenko, A. | Journal of substance abuse treatment | June 24, 2002

Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers

Riba, J., Anderer, P., Morte, A., Urbano, G., Jané, F., Saletu, B., & Barbanoj, M. J. | British journal of clinical pharmacology | 24 June 2002

The pharmacology of psilocybin

Passie, T., Seifert, J., Schneider, U., & Emrich, H. M. | Addiction Biology | 30 May 2002

Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach.

Lerner, A. G., Gelkopf, M., Skladman, I., & Oyffe, I. | The Israel journal of psychiatry and related sciences | 1 January 2002

No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography Study

Gamma, A., Buck, A., Berthold, T., & Vollenweider, F. X. | Journal of clinical psychopharmacology | 01 February 2001

Deconstructing Ecstasy: The Politics of MDMA Research

Grob, C. S. | Addiction Research & Theory | June 2000

LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study.

Lerner, A. G., Gelkopf, M., Oyffe, I., Finkel, B., Katz, S., Sigal, M., & Weizman, A. | International clinical psychopharmacology | 1 January 2000

Role of Serotoninergic Neurons and 5-HT Receptors in the Action of Hallucinogens

Nichols, D. E. | Serotoninergic Neurons and 5-HT Receptors in the CNS | 1 January 2000

Do entheogen-induced mystical experiences boost the immune system? Psychedelics, peak experiences, and wellness

Roberts, T. B. | Advances in Mind-Body Medicine | 1999

Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action

Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F., Bäbler, A., Vogel, H., & Hell, D. | Neuroreport | 1 Dec 1998

Serotonergic Agents That Activate 5HT2A Receptors Prevent NMDA Antagonist Neurotoxicity

Farber, N. B., Hanslick, J., Kirby, C., McWilliams, L., & Olney, J. W. | Neuropsychopharmacology | 2 July 1997

Ketamine psychedelic therapy (KPT): a review of the results of ten years of research

Krupitsky, E. M., & Grinenko, A. Y. | Journal of psychoactive drugs | 1997

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis

Vollenweider, F. X., Leenders, K. L., Scharfetter, C., Maguire, P., Stadelmann, O., & Angst, J. | Neuropsychopharmacology | October 1996

Increased Activation of Indirect Semantic Associations under Psilocybin

Spitzer, M., Thimm, M., Hermle, L., Holzmann, P., Kovar, K., Heirnann, H., ... Schneider, F. | Biological Psychiatry | 15 June 1996

The psychopharmacology of hallucinogens.

Abraham, H. D., Aldridge, A. M., & Gogia, P. | Neuropsychopharmacology | 1 April 1996

Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine’s putative anti-addictive activity

Sweetnam, P. M., Lancaster, J., Snowman, A., Collins, J. L., Perschke, S., Bauer, C., & Ferkany, J. | Psychopharmacology | 2 April 1995

Placeboing with Psychedelics

Roberts, T. B. | Advances: Journal of the Institute for the Advancement of Health | January 1987

Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens

Nichols, D. E. | Journal of psychoactive drugs | 1 January 1986

Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca

McKenna, D. J., Towers, G. N., & Abbott, F. | Journal of ethnopharmacology | 1 April 1984

LSD-assisted psychotherapy in patients with terminal cancer

Grof, S., Goodman, L. E., Richards, W. A., & Kurland, A. A. | International pharmacopsychiatry | 1973

LSD-assisted psychotherapy and the human encounter with death

Richards, W., Grof, S., Goodman, L., & Kurland, A. | Journal of Transpersonal Psychology | 1972

Attenuation and anticipation: A therapeutic use of lysergic acid diethylamide

Kast, E. | Psychiatric Quarterly | 1 October 1967

Psychedelic Agents in Creative Problem-Solving: A Pilot Study

Harman, W. W., McKim, R. H., Mogar, R. E., Fadiman, J., & Stolaroff, M. J. | Psychological Reports | 12 April 1966

Autistic Schizophrenic Children: An Experiment in the Use of D-Lysergic Acid Diethyladmide (LSD-25)

Freedman, A. M., Ebin, E. V., & Wilson, E. A. | Archives of General Psychiatry |1962

Schizophrenia: A New Approach (Continued)

Osmond, H., & Hoffer, A. | The British Journal of Psychiatry | July 1959

5‐Hydroxytryptamine. Pharmacological action and destruction in perfused lungs

Gaddum, J. H., Hebb, C. O., Silver, A., & Swan, A. A. B. | Quarterly journal of experimental physiology and cognate medical sciences | 10 Oct 1953